TW201041999A - Complex salts for light emitting devices - Google Patents

Complex salts for light emitting devices Download PDF

Info

Publication number
TW201041999A
TW201041999A TW099103172A TW99103172A TW201041999A TW 201041999 A TW201041999 A TW 201041999A TW 099103172 A TW099103172 A TW 099103172A TW 99103172 A TW99103172 A TW 99103172A TW 201041999 A TW201041999 A TW 201041999A
Authority
TW
Taiwan
Prior art keywords
alkyl
group
moiety selected
formula
represent
Prior art date
Application number
TW099103172A
Other languages
Chinese (zh)
Inventor
Mohammad Khaja Nazeeruddin
Etienne David Baranoff
Michael Graetzel
Original Assignee
Solvay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay filed Critical Solvay
Publication of TW201041999A publication Critical patent/TW201041999A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/08Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/18Metal complexes
    • C09K2211/185Metal complexes of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02BCLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO BUILDINGS, e.g. HOUSING, HOUSE APPLIANCES OR RELATED END-USER APPLICATIONS
    • Y02B20/00Energy efficient lighting technologies, e.g. halogen lamps or gas discharge lamps

Abstract

White light emitting material comprising a complex salt of the general formula[M1m+]x[M2n-]y wherein: xm = yn, [M1m+]and[M2n-] are ionic light emitting moieties which have complementary emission spectra, one emitting in the blue region of the visible spectra and the other, in the red region of the visible spectra, and wherein at least one of M1 and M2 is a metallic complex.

Description

201041999 六、發明說明: 【發明所屬之技術領域】 本發明涉及金屬錯鹽以及它們作爲發射材料在發光裝 置中的用途。具體來說它涉及它們在有機發光裝置(OLED) 中作爲白光發射體的用途。 【先前技術】 q 發射白光OLED可以藉由不同的技術來獲得。例如, 它們可以藉由使用多層構造而獲得,其中每層具有一不同 的發射光譜並且其中多個層的發射光譜係互補的並且覆蓋 整個的可見光譜,由此獲得了白光發射。另一方法係使用 具有寬的發射光譜的一種單一分子。還有另一方法係使用 在一個單一層中以不同波長發射的多個發射體。迄今爲止 那些方法涉及了中性的分子,因爲它們適合於真空製備的 小分子OLED。最經常使用的用於產生白光發射的方法涉 Q 及製造包括兩個或三個發射層的裝置。這使得製造白光發 射裝置(WOLED)係一種昂貴的方法而不能與實際的照明技 術競爭。 WO 2006/024997揭露了 一種三核的白光發射體分子 ,它包含兩個藍光發射的銥中心,銥中心藉由一有機的連 接被配位至一紅光發射的銪錯合物上,其中從高能量發射 中心向低能量發射中心的部分的能量傳遞導致了幾乎是白 光的發射。這種在共價鍵合的發射中心之間的部分的能量 傳遞可以藉由對兩個發射中心之間的連接物(藉由調整連 -5- 201041999 接基團的長度)仔細地工程處理來進行控制。這要求冗長 且繁重的有機化學處理。 【發明內容】 本發明的一目的係提供容易製備並且其中能量轉移的 程度容易控制的發射體,尤其是白光發射體。 在一弟一方面,本發明涉及一種發光材料,該發光材 料包括一錯鹽’該錯鹽由一或多個陰離子發光部分 (moiety)的一基團構成,該等部分補償了一或多個陽離子 發光部分的一基團的電荷,其中所述部分的至少一個係一 種金屬的錯合物’較佳的是所述兩個部分都是金屬的錯合 物。在多個實施方式中,該等部分具有互補的發射光譜這 樣該發光材料可以起到一白光發射材料的作用。每個發光 部分可以是一磷光質。具體來說,第一方面的多個實施方 式涉及含一種通式爲的錯鹽的白光發射材 料,其中: • xm = yn, • [M^ + l和[M^]係離子的發光部分,它們具有互補的發 射光譜,一個在可見光譜的藍色區域內發射,而另一個在 可見光譜的紅色區域內,並且 其中Μ ,和Μ2的至少一個係一種金屬的錯合物。 在一第二方面’本發明涉及用於製備根據本發明的第 一方面的發射材料並且特別是一錯鹽的方法。 在一第三方面,本發明涉及一種包括一發射層的發光 -6- 201041999 裝置’所述發射層包括或由一種根據本發明的第一方面的 一種發光材料所組成。 在一第四方面,本發明涉及根據本發明的第一方面的 白光發射材料在一種發光裝置的一發射層中的用途。 本發明的多個實施方式的一優點在於白光發射可以藉 由一個單一層的材料而獲得。單一發射層的裝置係更容易 且更便宜製造的。 q 本發明的多個實施方式的另一優點在於它們藉由允許 對該金屬錯鹽的每個發射體的單獨最佳化提供了對於細微 調整的發射的一通用的方法。 本發明的多個實施方式的再另一優點在於只要求最小 數目的合成步驟來製備該發射材料,而先前技術要求一連 接物的合成性的結合。 本發明的多個實施方式的另一優點在於在根據本發明 的多個實施方式的一發射體的能量供體和能量受體部分之 Q 間的能量傳遞的程度可以藉由改變該發射體與之接觸的介 質的極性(局部的和/或整體的極性)、和/或藉由改變其中 極性摻雜劑的濃度來容易地進行控制。在現有技術中,改 變能量傳遞的程度暗示著藉由一新的合成來改變連接物的 長度。 本發明的特別的並且較佳的方面在所附的獨立的和從 屬的申請專利範圍中提出。來自從屬申請專利範圍的多項 特徵可以與獨立的申請專利範圍的特徵進行組合、並在合 適時與其他從屬申請專利範圍的特徵進行組合,而不是僅 201041999 僅如在該等申請專利範圍書中所清楚給出的那樣。 儘管在本領域中已經有了對裝置的不斷改進、改變以 及演化,相信本申請的槪念代表了實質性的新穎的改進, 包括脫離了先前的慣例,從而導致提供了這種性質的更有 效的、穩定的以及可靠的裝置。 本發明的上述以及其他的特性、特徵和優點將從以下 結合附圖的詳細說明中變得清楚,該等附圖作爲舉例說明 了本發明的原則。給出該說明只是因爲舉例的原因,並不 限制本發明的範圍。以下引證的參考數字指的是所附的圖 說明性實施方式的說明 將相對於具體的實施方式並參考某些附圖來對本發明 進行說明但本發明並不受限於此而只受申請專利範圍限制 。描述的附圖只是示意性的並且爲非限制性的。在圖中, 爲了解說的目的一些要素的尺寸可能被誇大而並非按照比 例繪出。量綱和相關的量綱並不對應于對本發明的付諸實 施。 另外,在說明和申請專利範圍中的術語第一、第二、 第三以及類似術語係用於在相似的要素之間進行區分而並 非必須是爲了說明一種順序,無論是時間上、空間上、等 級上或任何其他形式上。應當理解如此使用的術語在適當 的情形下是可互換的,並且在此描述的本發明的實施方式 能夠以除了在此說明或展示的之外的其他順序操作。 -8 _ 201041999 此外,該說明書和申請專利範圍書中的術語頂部、底 部、之上、之下以及類似術語係爲描述的目的而使用的並 非必須是爲了說明相對位置。應理解如此使用的術語在適 當的情形下是可互換的並且在此描述的本發明的實施方式 能夠以除了在此描述或說明的之外的其他調整來操作。 應該注意的是在該申請專利範圍書中使用的術語“包 括”,不應被理解爲限制於其後所列出的含義,它並不排 0 除其他要素或步驟。因此它應被理解爲對所述特徵 '整體 、步驟或涉及到的組分的存在進行詳細說明,但它並不排 除一或多個其他特徵、整體、步驟或組分、或它們的基團 的存在或加入。因此,表述“包括部件A和B的一裝置”的 範圍不應該限制於僅由部件A和B構成的裝置。它係指就 本發明而言,該裝置僅有的相關的部件係A和B。 貫穿該說明書的提及“一實施方式”或“實施方式”係指 結合該實施方式描述的一具體的特徵、結構或特性包含在 Ο 本發明的至少一個實施方式中。因此,貫穿該說明書在不 同地方出現的短語“在一實施方式中”或“在實施方式中”不 是必須都指同一實施方式,但是可以。另外,具體的特徵 、結構或特性能以任何合適的方式進行組合,如對本領域 中的熟習該項技術者自本揭露內容的一或多個實施方式係 清楚的。 同樣地,應該理解的是在本發明的實例性實施方式的 說明中,爲了使揭露內容合理並説明理解本發明的一或多 個不同方面的目的,本發明的不同特徵有時被一起組合在 -9 - 201041999 一單個實施方式、附圖、或它們的說明中。然而,本揭露 的方法不得被解釋爲反映了一種意圖,即本提出申請專利 範塵I的發明要求多於每項申請專利範圍中清楚引用的特徵 。而是’如以下申請專利範圍所反映的,多個發明的方面 係在於要少於一單個的以上揭露的實施方式的全部特徵。 因此’特此明確地將詳細說明之後的申請專利範圍結合在 該詳細說明之中,其中每個申請專利範圍以其本身作爲本 發明的一單獨的實施方式。 此外’雖然在此描述的一些實施方式包括了一些但不 是包含在其他實施方式中的其他特徵,但是不同實施方式 的特徵的組合係指在本發明的範圍之中,並且形成了不同 的實施方式,如應該被本領域的普通人員所理解的。例如 ,在下面的申請專利範圍中,申請專利範圍的實施方式中 的每一個都能以任意的組合使用。 在在此提供的說明書中,列出了大量的具體細節。然 而,要理解的是本發明的該等實施方式可以不具有該等具 體細節而被實施。在其他例子中,爲了不妨礙對本說明書 的理解,並未詳細示出普遍已知的方法、結構和技術。 提供以下術語僅僅是爲了幫助理解本發明。 除非另外提供,否則如在此使用的術語“電洞傳輸聚 合物”或“電洞傳導聚合物”係指一半傳導的聚合物,其傳 輸電洞的能力比它傳輸電子的能力更高。 除非另外提供,否則如在此使用的術語“電子傳輸聚 合物”或“電子傳導聚合物”係指一半傳導的聚合物,其傳 -10- 201041999 輸電子的能力比它傳輸電洞的能力更高。 除非另外提供’否則如在此使用的術語“小分子”係指 具有高達2000 g/mol的分子量的一種分子。 現在藉由對本發明的一些實施方式的一詳細說明來對 本發明進行說明。很明顯可以按照本領域的熟習該項技術 者的知識來配置本發明的其他實施方式,而並不脫離本發 明的真實精神或技術內容,本發明只受所附申請專利範圍 0 的術語限制。 本發明的多位發明人已經意識到,爲了獲得一單層發 射裝置’如果用作一種發射材料,具有兩個不發射的相對 離子的兩種帶不同電荷的離子錯合物的一簡單的混合物將 展現出多種不便。這樣一混合物的第一缺點將是來自相對 離子的鹽類可能結晶。例如,假如將具有相對陰離子X, 的一陽離子發光錯合物(即一離子對[Μ/ΠΧ〆])、以及 具有相對陽離子x2的一陰離子發光錯合物m2(即一離子對 Q [Μ2Ί[Χ2 + ])混合在一起,則鹽[xr][x2 + ]可能容易地長期結 晶’因爲那些相對離子通常是由可以牢固鍵合的非常小的 分子(PF6_,··.)或原子(Cl-、Na+···)構成的。並且,例如,假 如將一離子對[Μ/ΠΧ〆]、和一離子對[Μ2 + ][χ2-;|混合在一 起’則兩種發射的錯合物將終結在該裝置的同一側,從而 增加猝滅的可能性。 另外’製備不結晶的具有相對離子的錯合物(物像例 如離子液體衍生物相對離子),可能是困難的且昂貴的, 因爲會要求一離子交換步驟。該步驟可能涉及到這種所尋 -11 - 201041999 求的相對離子的一飽和溶液、以及預期的錯合物的; 爲克服那些合成步驟,已經出乎意料地發現靜 子鍵以及更具體的是離子超分子鍵可以用來將兩個 的發光部分連在一起。 在第一方面,本發明涉及一種包括一錯鹽的發 ,該錯鹽由一或多個陰離子發光部分(moiety)的一 成,該等部分補償了一或多個陰離子發光部分的一 電荷,其中所述部分的至少一個係一種金屬的錯合 多個實施方式中,該等部分具有互補的發射光譜這 光材料可以起到一種白光發射材料的作用。每個發 可以是一磷光的部分或一螢光的部分,它較佳的是 的部分。 本發明的第一方面的多個實施方式涉及包括一 的錯鹽的一種發光材料,其中·· 1 . Μ 1係一陽離子的發光部分, 2. μ2係一陰離子的發光部分, 3. xm = yn,並且 其中Μ 1和M2的至少一個係一種金屬錯合物。 在多個實施方式中,[M^ + h和以广;^具有互 射光譜這樣該發光材料係一種白光發射材料。 在一實施方式中,該等錯鹽的特徵在於[M, [M2n_]y中的一個在可見光譜的藍色區域內發射(從 到天藍色和偏綠的藍色’例如,其發射光譜具有在 至550 nm、較佳的是390 nm至520 nm的範圍內 冗澱。 電超分 或更多 光材料 基團組 基團的 物。在 樣該發 光部分 一磷光 通式爲 補的發 m + ]x 和 深藍色 3 9 0 n m 的最大 -12- 201041999 發射波長)並且另一個在可見光譜的紅色區域內發射(從黃 橙色至紅色,例如,其發射光譜具有在550 nm至740 nm 、較佳的是在5 80 nm至740 nm範圍內的最大發射波長) 。換言之,本發明的多個實施方式涉及根據以上任何實施 方式的白光發射材料,其中[M^ + h和以广;^中的一個其 發射光譜具有在550 nm至740 nm範圍內的最大發射波長 ,並且另一個其發射光譜具有在390 nm至550 nm範圍內 的最大發射波長。較佳的是,該等部分之間的距離(例如 ,在一離子對的情況下,[M^ + h和[M2n」y之間)被調節和 /或該等部分被選擇(例如,選擇[ΜΛ + h和[M2n_]y)爲使得 所述金屬鹽能夠發射具有在從(0.200,0.200)至(0.550, 0.500)、較佳的是從(0.260,0.280)至(0.460,0.500),更 佳的是從(0.270,0.290)至(0.400,0.400)範圍內的 CIE 1931座標(X,y)的光。換言之,本發明的多個實施方式涉 及根據以上任何實施方式的白光發射材料,其中該錯鹽能 夠發射具有在從(0.200,0.200)至(0.550,0.500)範圍內的 CIE 1931座標(X,y)的光。這係有利的,因爲具有這樣的 CIE 1931座標的光係可接受的白光。對該等部分(例如 [ΜΠχ和[M2nJy)之間的距離的調整可以藉由將該錯鹽包 含在一基質中(較佳的是分散在一基質中)而進行,其中包 圍該等金屬錯鹽的基質的極性(例如整體和/局部的極性)被 調整爲適合提供該等發光部分之間的一個距離使得白光的 發射可以發生。 當一基質存在時,該錯鹽(即所尋找之物)能以0.05% -13- 201041999 或更多、較佳的是ο · 1 ο %或更多、特別佳的是0 .1 5 %或更 多且尤其佳的是0_2〇 %或更多的量存在。 客體能以2 0 %或更少、較佳的是1 5 %或更少、特別佳 的是1〇%或更少並且尤其佳的是5%或更少的量値存在, 其中該等上限中的任一個可以與以上下限中的任一個進行 組合。本發明的多個實施方式涉及包括一種如以上任何實 施方式中所定義的錯鹽以及一基質的發光材料,其中所述 基質的極性係足以在該等發光部分之間提供一個距離這樣 白光的發射可以發生。該基質可以是一液體、凝膠或固體 的極性的、非離子的介質。該基質較佳的是一固體介質。 該基質的主要組分較佳的是非離子的但是該非離子的基質 可以摻雜極性的種類(諸如離子的種類)。在多個實施方式 中,該非離子的基質可以是疏質子的。該基質較佳的是包 括一聚合物作爲它的主要的或唯一的組分。可隨意地,該 基質的光學特性(例如’它的吸收特性)可以用來調整(例如 ,校正)該發光錯鹽的發射光譜。該基質較佳的是可透過 可見光的。提供一適合於在該等部分之間提供足夠距離的 基質的一良好的方式係選擇一極性的基質。該基質較佳的 是具有至少等於聚(乙烯吡咯烷酮)(PVP)極性的—個極性, 即小於3.0。 合適的極性基質進一步起到電洞傳輸和/或電子傳輸 有機半導體的作用,除其他之外,包括例如聚(乙烯咔唑 )(P V K)和/或聚合的或非聚合性的噁二唑。 介電常數(或相對靜電介電常數)係對該基質的宏觀極 -14- 201041999 性的一衡量。假如該基質的介電常數小於PVP的介電常數 (例如,小於3.0),那麼較佳的是在該基質中包含一或多 個的第二組分(或“摻雜劑”)。那些摻雜劑係極性的分子。 那些極性的分子較佳的是能夠使該錯鹽中連接該等離子部 分的一或多個靜電的(離子的)鍵鬆開或斷裂。該等摻雜劑 較佳的是離子的鹽。離子的鹽會説明分離該等發射部分。 摻雜劑的實例係有機陽離子與或者有機的或者無機的陰離 Q 子的結合的鹽類。當處於液體形式時,它們係指離子液體 或熔融的鹽。離子的液體包括一熔融鹽,它在室溫下係液 體並且還可以包括一所謂的“環境溫度熔融鹽’,,它具有一 個低於15(TC、較佳的是低於80t且更佳的是低於30。(:的 熔點。 離子液體係由一種陽離子和一種陰離子組成(如在一 規則的鹽中)的化合物。區別特徵係該化合物的低溫熔點 。其熔點可以是低於室溫或處於相對低的升高的溫度下( 〇 例如1 50°C ),從而使得它們與聚合的膜是相容的(當處於 它們的液態時)。用於離子液體的陽離子的實例係:單、 雙和二取代的咪哩綠、卩it u定鑰、噠嚓鐵、嚼π定鎗、啦略院 鑰類、吡嗪鐵、吡唑鑰、噻唑鑰、噁唑鑰、三唑鐵、磷鑰 類、銨類、胍鑰類、以及異脲鍚。用於離子液體的陰離子 的實例係:鹵化物類、硫酸鹽類、磺酸鹽類(例如三氟甲 基磺酸鹽(“三氟甲磺酸鹽”,CF3S〇3-))、醯胺類、醯亞胺 類(例如雙(三氟甲基磺醯基)醯亞胺((N(CF3S02)2-)、雙(全 氟乙基磺醯基)醯亞胺((C:2F5S〇2)2N·))、甲基化物類(例如 -15- 201041999 ’三(三氟甲基磺醯基)甲基化物((CF3so2)3cr))、硼酸鹽類 (例如四氟硼酸鹽(bf4-))、磷酸鹽類(例如六氟磷酸鹽(pf6-))、銻酸鹽類(例如六氟銻酸鹽(SbF6·))、砷酸鹽類(例如六 氟砷酸鹽(AsF〇)、四羰合鈷 '三氟醋酸鹽、以及癸酸鹽 〇 當存在時,該摻雜劑能以 0.05%或更多、0.10%或更 多、0.15%或更多、或〇.2〇 %或更多的量値存在。該摻雜 劑能以2 0 %或更少、1 5 %或更少、1 0 %或更少、或5 %或更 少的量値存在’其中該等上限的任一個可以與以上下限的 任一個進行組合。當一客體存在時,該基質中的錯鹽與極 性摻雜劑的莫耳比可以是例如1 . 5或更小、1 . 3或更小、 1 · 2或更小、1 . 1或更小、1 . 〇 5或更小、〇 · 5或更大、0.7 或更大、或更大、0.9或更大、0.95或更大,其中任何 下限可以與任何上限進行組合。假如該基質的主要組分係 比PVP極性更小的,儘管如此,則可以加入極性的(例如 離子的)摻雜劑分子來進一步將該等部分分開。構成本發 明的金屬鹽的該等部分通常可以藉由能量傳遞(取決於分 開它們的距離)而相互作用。例如,在包括一藍光發射陽 離子和一紅光發射陰離子的離子對的情況下,該藍光發射 的陽離子很可能將其全部或部分的能量傳遞至該紅光發射 的陰離子(這將取決於該藍光發射體的發射光譜與該紅光 發射體的吸收光譜之間的重疊的程度並且取決於這兩個發 射體之間的距離以及它們的平均相對方向)°假如能量傳 遞太多,則該離子對將在該藍光發射體的激發下發射紅光 -16- 201041999 。μ 了丨吏該離子對發射出可以被認爲是白光的光(例如在 從(0.200 , 0.200)、較佳的是從(0.260 , 0.280)至(0.550 ’ 0.500)、較佳的是至(0·460,0·500)的範圍內具有CIE 1931 座標(x , y)的光)’通常要求在該等發射部分之間具有充足 的距離。更高的距離胃減小胃等發射部分之間的能i傳遞 的程度。當具有互補的發射光譜的該等發射部分之間的距 離使得能量傳遞發生至這樣一個程度’即這兩個部分都發 0 射出具有的相對強度使得人眼將該光混合物感覺爲白光的 光時,將獲得白光發射。如以上實例中描述的一離子對的 情況可以延伸至包括超過兩個發射種類的情況。 對於本發明的性能,有利的地是將構成錯鹽的發射部 分以這樣一種方式選擇爲它們的發射光譜係互補的,即當 每個發射部分發射出足夠強度的光時,它們的發射光譜覆 蓋可見光譜的一足夠大的部分來產生白光發射。該等強度 的足夠量可以藉由調整該等發射部分之間的距離來滿足, Q 這係例如藉由如上所述調整一周圍的基質的極性。該等部 分之間的恰當的距離取決於所選部分的性質。這個距離可 以由本領域的熟習該項技術者使用本申請中所提供的指導 來決定。對於白光發射,儘管對於每種錯鹽都存在著該等 發射部分之間的一理想的距離範圍,但是太大的距離通常 會導致自白光的較小偏離而太小的距離通常導致自白光的 更多偏離(當該等部分之間的距離太小時光很容易強烈地 紅移)。較佳的是’ Μ,和M2都是金屬的錯合物。該實施 方式的主要優點係確保來自該錯鹽的兩個部分的磷光。純 -17- 201041999 的有機分子(在這種情況下與金屬錯合物是相反的)通常是 螢光的。假如在該有機分子上發生載體重組並且沒有能量 傳遞發生,這可能導致效率的損失。另一優點係藉由使用 金屬錯合物來獲得帶電荷的發射體的簡單性。最後,該等 錯合物中的電荷通常是內部的,即帶電荷的金屬離子已經 被多個配位基所包圍,特別是在八面體錯合物的情況下, 然而在有機分子中’電荷通常是在週邊,因爲它們來自帶 電荷的取代基的接枝。因爲靜電吸引高度依賴於電荷之間 的距離,當使用有機分子時預期到更強的相互作用,這要 求使更加極性的聚合物或更強的電場分離開以便白光發射 。合適的金屬的⑷或M2的實例有銀、釕、錢、銶、鈾、 金、餓、鋅、鎘、汞、銅或銀的發光的帶電荷的錯合物。 較佳的金屬性Μ!* Mz係銥、釕、鍺、銶、鉑、金、餓的 發光的帶電荷的錯合物。 金屬的發射陽離子的實例在以下示出: -18- 201041999201041999 VI. Description of the Invention: TECHNICAL FIELD OF THE INVENTION The present invention relates to metal-missing salts and their use as emissive materials in illuminating devices. In particular it relates to their use as white light emitters in organic light-emitting devices (OLEDs). [Prior Art] q The white light emitting OLED can be obtained by different techniques. For example, they can be obtained by using a multilayer construction in which each layer has a different emission spectrum and in which the emission spectra of the plurality of layers are complementary and cover the entire visible spectrum, thereby obtaining white light emission. Another method uses a single molecule with a broad emission spectrum. Yet another method uses multiple emitters that emit at different wavelengths in a single layer. Those methods to date involve neutral molecules because they are suitable for small molecule OLEDs prepared by vacuum. The most frequently used method for producing white light emissions involves Q and the fabrication of devices comprising two or three emissive layers. This makes the manufacture of white light emitting devices (WOLEDs) an expensive method that does not compete with actual lighting technology. WO 2006/024997 discloses a trinuclear white light emitter molecule comprising two blue-emitting enthalpy centers, the enthalpy center being coordinated to a red-emitting erbium complex by an organic linkage, wherein The energy transfer from the high energy emission center to the portion of the low energy emission center results in the emission of almost white light. The energy transfer of this portion between the covalently bonded emission centers can be carefully engineered by the connection between the two emission centers (by adjusting the length of the connection group - 5 - 201041999) Take control. This requires lengthy and cumbersome organic chemical treatment. SUMMARY OF THE INVENTION One object of the present invention is to provide an emitter, particularly a white light emitter, that is easy to prepare and in which the degree of energy transfer is easily controlled. In one aspect, the invention relates to a luminescent material comprising a salt of a wrong salt which consists of a group of one or more anionic luminescent moieties which compensate for one or more The charge of a group of the cationic luminescent moiety, wherein at least one of the moieties of the moiety is a complex of the metal, preferably the two moieties are metal complexes. In various embodiments, the portions have complementary emission spectra such that the luminescent material can function as a white light emitting material. Each of the illuminating portions may be a phosphorescent material. In particular, various embodiments of the first aspect relate to a white light emitting material comprising a salt of the general formula, wherein: • xm = yn, • [M^ + l and [M^] light-emitting portions of the ion, They have complementary emission spectra, one emitting in the blue region of the visible spectrum and the other in the red region of the visible spectrum, and wherein at least one of Μ and Μ2 is a metal complex. In a second aspect the invention relates to a process for the preparation of an emissive material according to the first aspect of the invention and in particular a fault salt. In a third aspect, the invention relates to a luminescent device comprising an emissive layer -6-201041999 apparatus' said emissive layer comprising or consisting of a luminescent material according to the first aspect of the invention. In a fourth aspect, the invention relates to the use of a white light-emitting material according to the first aspect of the invention in an emissive layer of a light-emitting device. An advantage of various embodiments of the present invention is that white light emission can be obtained by a single layer of material. A single emissive layer device is easier and cheaper to manufacture. Another advantage of various embodiments of the present invention is that they provide a versatile method for finely tuned emission by allowing for individual optimization of each emitter of the metal mis-salt. Yet another advantage of various embodiments of the present invention is that only a minimum number of synthetic steps are required to prepare the emissive material, whereas the prior art requires a synthetic combination of connectors. Another advantage of various embodiments of the present invention is that the degree of energy transfer between the energy donor and energy acceptor portions of an emitter in accordance with various embodiments of the present invention can be varied by altering the emitter and The polarity of the medium being contacted (local and/or overall polarity), and/or by the concentration of the polar dopant therein is easily controlled. In the prior art, varying the degree of energy transfer implies changing the length of the link by a new synthesis. Particular and preferred aspects of the invention are set forth in the accompanying independent and dependent claims. A number of features from the scope of the dependent patent application may be combined with features of the independent patent application scope and, where appropriate, in combination with features of other subordinate patent applications, and not only 201041999, as only in the scope of the patent application. As clearly stated. While there have been continual improvements, changes, and evolutions to the device in the art, it is believed that the commemoration of the present application represents a substantial novel improvement, including departure from prior practice, thereby resulting in a more effective provision of this property. , stable and reliable device. The above and other features, features and advantages of the present invention will become apparent from This description is given for the sake of example only and does not limit the scope of the invention. The following referenced numerals refer to the accompanying drawings. The description of the illustrative embodiments will be described with respect to the specific embodiments and with reference to certain drawings, but the invention is not limited thereto but only patented. Range limit. The drawings described are only schematic and are non-limiting. In the figures, the dimensions of some of the elements may be exaggerated and not drawn to scale. The dimensions and related dimensions do not correspond to the practice of the invention. In addition, the terms first, second, third and similar terms used in the description and claims are used to distinguish between similar elements and not necessarily to illustrate a sequence, whether temporally or spatially. Level or any other form. It is to be understood that the terms so used are interchangeable, and the embodiments of the invention described herein are capable of operation in other sequences than those described or illustrated herein. -8 _ 201041999 In addition, the terms top, bottom, over, under, and the like in the specification and claims are used for the purpose of description and are not intended to illustrate the relative position. It is to be understood that the terms so used are interchangeable under the appropriate circumstances and the embodiments of the invention described herein can be practiced with other modifications than those described or illustrated herein. It should be noted that the term "comprising", which is used in the scope of the claims, is not to be construed as limited to the meaning It is therefore to be understood that the description of the features as a whole, the steps, or the presence of the components are described in detail, but it does not exclude one or more other features, integers, steps or components, or groups thereof Exist or join. Therefore, the scope of the expression "a device including components A and B" should not be limited to a device composed only of components A and B. It refers to the only relevant components A and B of the device for the purposes of the present invention. References to "an embodiment" or "an embodiment" in this specification means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment of the invention. Thus, the appearance of the phrase "in an embodiment" or "in an embodiment" In addition, specific features, structures, or characteristics may be combined in any suitable manner, as will be apparent to those skilled in the art from this disclosure. Likewise, it is to be understood that in the description of the exemplary embodiments of the present invention, the various features of the invention are sometimes combined together in order to clarify the disclosure and to explain the purpose of understanding one or more different aspects of the invention. -9 - 201041999 A single embodiment, a drawing, or a description thereof. However, the method of the present disclosure should not be construed as reflecting an intention that the invention claims of the present patent application are more than those clearly recited in the scope of each patent application. Rather, as reflected in the scope of the claims below, the aspects of the various embodiments are in less than all the features of a single disclosed embodiment. Therefore, the scope of the patent application is hereby incorporated by reference in its entirety in its entirety herein in the claims Further, although some embodiments described herein include some other features that are not included in other embodiments, combinations of features of different embodiments are within the scope of the invention and different embodiments are formed. As should be understood by those of ordinary skill in the art. For example, in the following claims, each of the embodiments of the claims can be used in any combination. Numerous specific details are set forth in the description provided herein. However, it is to be understood that the embodiments of the invention may be practiced without these specific details. In other instances, well-known methods, structures, and techniques have not been shown in detail in order not to obscure the understanding of the specification. The following terms are provided merely to assist in understanding the invention. The term "hole transport polymer" or "hole-conducting polymer" as used herein, unless otherwise provided, refers to a semi-conducting polymer that has a higher ability to transport holes than it transmits electrons. The term "electron transport polymer" or "electron conducting polymer" as used herein, unless otherwise provided, refers to a semi-conducting polymer that transmits -10-201041999 with the ability to transport electrons more than it transmits holes. high. Unless otherwise provided, the term "small molecule" as used herein refers to a molecule having a molecular weight of up to 2000 g/mol. The invention will now be described by way of a detailed description of some embodiments of the invention. It is apparent that other embodiments of the present invention can be configured in accordance with the knowledge of those skilled in the art without departing from the true spirit or scope of the invention. The invention is limited only by the terms of the appended claims. A number of inventors of the present invention have recognized that in order to obtain a single layer emitter, 'if used as an emissive material, a simple mixture of two differently charged ion complexes with two non-emitting opposite ions Will show a variety of inconveniences. A first disadvantage of such a mixture would be that the salts from the opposite ions may crystallize. For example, if a cationic luminescent complex (ie, an ion pair [Μ/ΠΧ〆]) having a relative anion X, and an anionic luminescent complex m2 having a relative cation x2 (ie, an ion pair Q [Μ2Ί] [Χ2 + ]) When mixed together, the salt [xr][x2 + ] may easily crystallize for a long time 'because those relative ions are usually made up of very small molecules (PF6_, . . . ) or atoms that can be firmly bonded ( Cl-, Na+···). And, for example, if an ion pair [Μ/ΠΧ〆], and an ion pair [Μ2 + ][χ2-;| are mixed together, then the two emitted complexes will end on the same side of the device, Thereby increasing the possibility of annihilation. In addition, the preparation of non-crystalline, relatively ionic complexes (such as ionic liquid derivatives versus ions) can be difficult and expensive because an ion exchange step would be required. This step may involve a saturated solution of the relative ions sought in -11 - 201041999, as well as the expected complex; to overcome those synthetic steps, it has been unexpectedly found that the stator bond and more specifically the ion A supramolecular bond can be used to join the two illuminating portions together. In a first aspect, the invention relates to a hair comprising a fault salt consisting of one or more anionic light-emitting moieties that compensate for a charge of one or more anionic light-emitting portions, Wherein at least one of the portions is a misalignment of a plurality of embodiments, the portions have complementary emission spectra. The optical material can function as a white light emitting material. Each hair may be a phosphorescent portion or a fluorescent portion, which is preferably a portion. A plurality of embodiments of the first aspect of the invention relate to a luminescent material comprising a salt of a fault, wherein · 1 is a luminescent portion of a cation, 2. π is an illuminating portion of an anion, 3. xm = Yn, and wherein at least one of Μ 1 and M 2 is a metal complex. In various embodiments, [M^ + h and Å; ^ have an inter-spectral spectrum such that the luminescent material is a white light-emitting material. In one embodiment, the equal salt is characterized by one of [M, [M2n_]y emitting in the blue region of the visible spectrum (from blue to greenish and greenish blue), eg, its emission spectrum has Residues in the range of 550 nm, preferably 390 nm to 520 nm. Electrically super- or more materials of the group of photo-material groups. In the case of the luminescent part, a phosphorescent formula is a supplementary m. + ]x and dark blue 309 nm maximum -12-201041999 emission wavelength) and the other emits in the red region of the visible spectrum (from yellow-orange to red, for example, its emission spectrum is between 550 nm and 740 nm, Preferred is the maximum emission wavelength in the range of 580 nm to 740 nm). In other words, various embodiments of the present invention relate to a white light emitting material according to any of the above embodiments, wherein one of [M^ + h and Y, guang; has an emission spectrum having a maximum emission wavelength in a range of 550 nm to 740 nm And another of its emission spectrum has a maximum emission wavelength in the range of 390 nm to 550 nm. Preferably, the distance between the portions (eg, in the case of an ion pair, between [M^ + h and [M2n" y) is adjusted and/or the portions are selected (eg, selected [ΜΛ + h and [M2n_]y) such that the metal salt is capable of emitting at (0.200, 0.200) to (0.550, 0.500), preferably from (0.260, 0.280) to (0.460, 0.500), More preferably, the light of the CIE 1931 coordinates (X, y) ranges from (0.270, 0.290) to (0.400, 0.400). In other words, various embodiments of the present invention relate to a white light emitting material according to any of the above embodiments, wherein the fault salt is capable of emitting a CIE 1931 coordinate (X, y) having a range from (0.200, 0.200) to (0.550, 0.500) ) the light. This is advantageous because light with such a CIE 1931 coordinate is acceptable for white light. The adjustment of the distance between the parts (eg [ΜΠχ and [M2nJy]) can be carried out by including the wrong salt in a matrix, preferably dispersed in a matrix, wherein the metal is surrounded The polarity of the matrix of the salt (e.g., the overall and/or local polarity) is adjusted to provide a distance between the illuminating portions such that emission of white light can occur. When a substrate is present, the wrong salt (i.e., the object sought) can be 0.05% -13 - 201041999 or more, preferably ο · 1 ο % or more, particularly preferably 0.15% Or more and especially preferably an amount of 0_2% or more is present. The object can be present in an amount of 20% or less, preferably 15% or less, particularly preferably 1% or less, and particularly preferably 5% or less, wherein the upper limit Any of the above may be combined with any of the above lower limits. Embodiments of the present invention are directed to a luminescent material comprising a fault salt as defined in any of the above embodiments and a substrate, wherein the polarity of the substrate is sufficient to provide a distance between the illuminating portions such that white light is emitted Can happen. The substrate can be a liquid, gel or solid polar, nonionic medium. The substrate is preferably a solid medium. The main component of the matrix is preferably nonionic but the nonionic matrix can be doped with a polar species such as the species of ions. In various embodiments, the non-ionic substrate can be aprotic. Preferably, the substrate comprises a polymer as its primary or sole component. Optionally, the optical properties of the substrate (e.g., ' its absorption characteristics) can be used to adjust (e. g., correct) the emission spectrum of the luminescent salt. The substrate is preferably permeable to visible light. A good way to provide a substrate suitable for providing a sufficient distance between the portions is to select a substrate of a polarity. Preferably, the substrate has a polarity at least equal to the polarity of the poly(vinylpyrrolidone) (PVP), i.e., less than 3.0. Suitable polar matrices further function as a hole transport and/or electron transport organic semiconductor, including, for example, poly(vinylcarbazole) (P V K) and/or polymeric or non-polymeric oxadiazole. The dielectric constant (or relative electrostatic dielectric constant) is a measure of the macroscopic polarity of the matrix -14-201041999. If the dielectric constant of the matrix is less than the dielectric constant of PVP (e.g., less than 3.0), it is preferred to include one or more second components (or "dopants") in the matrix. Those dopants are molecules of polarity. Those polar molecules are preferably capable of loosening or breaking one or more electrostatic (ionic) bonds in the wrong salt that are attached to the plasma portion. These dopants are preferably ionic salts. The salt of the ion will indicate the separation of the emitting moieties. Examples of dopants are salts of organic cations with either organic or inorganic anions. When in liquid form, they are meant to mean ionic liquids or molten salts. The ionic liquid comprises a molten salt which is liquid at room temperature and which may also comprise a so-called "ambient temperature molten salt" having a lower than 15 (TC, preferably less than 80 t and more preferably Is a melting point below 30. (: melting point. The ionic liquid system consists of a cation and an anion (as in a regular salt). The distinguishing feature is the low melting point of the compound. Its melting point can be lower than room temperature or At relatively low elevated temperatures (〇, for example, 1 50 ° C), such that they are compatible with the polymerized membrane (when in their liquid state). Examples of cations for ionic liquids are: Double and disubstituted imipenyl green, 卩it u key, sputum iron, chew π fixed gun, lyrics key, pyrazine iron, pyrazole key, thiazole key, oxazole key, triazole iron, phosphorus Keys, ammoniums, samariums, and isoureaces. Examples of anions used in ionic liquids are: halides, sulfates, sulfonates (eg, trifluoromethanesulfonate ("trifluoro Mesylate salt, CF3S〇3-)), guanamines, quinones (for example Bis(trifluoromethylsulfonyl) quinone imine ((N(CF3S02)2-), bis(perfluoroethylsulfonyl) quinone imine ((C:2F5S〇2)2N·)), A Bases (eg -15-201041999 'Tris(trifluoromethylsulfonyl)methide ((CF3so2)3cr)), borate (eg tetrafluoroborate (bf4-)), phosphate ( For example, hexafluorophosphate (pf6-)), phthalates (such as hexafluoroantimonate (SbF6·)), arsenates (such as hexafluoroarsenate (AsF〇), cobalt tetracarbonyl” The fluoroacetate, and the bismuth citrate, when present, can be present in an amount of 0.05% or more, 0.10% or more, 0.15% or more, or 0.2% by weight or more. The dopant can be present in an amount of 20% or less, 15% or less, 10% or less, or 5% or less, wherein any of the upper limits can be combined with the lower limit Any one of them is combined. When a guest is present, the molar ratio of the wrong salt to the polar dopant in the matrix may be, for example, 1.5 or less, 1.3 or less, 1 or 2 or less. , 1.1 or less, 1. 〇5 or less, 〇·5 or greater, 0.7 or Large, or greater, 0.9 or greater, 0.95 or greater, where any lower limit can be combined with any upper limit. If the primary component of the matrix is less polar than PVP, nevertheless it can be polar ( For example, ionic dopant molecules further separate the moieties. The moieties that make up the metal salt of the present invention can generally interact by energy transfer (depending on the distance separating them). For example, including a blue light In the case of an ion pair emitting a cation and a red-emitting anion, the blue-emitting cation is likely to transfer all or part of its energy to the red-emitting anion (which will depend on the emission spectrum of the blue emitter) The extent of overlap between the absorption spectra of the red emitters and on the distance between the two emitters and their relative relative orientation). If the energy transfer is too much, the ion pair will be in the blue emitter The excitation of the red light is emitted -16-201041999. The ion pair emits light that can be considered white light (for example, from (0.200, 0.200), preferably from (0.260, 0.280) to (0.550 '0.500), preferably to ( Light having a CIE 1931 coordinate (x, y) in the range of 0·460, 0·500) generally requires a sufficient distance between the emitting portions. The higher distance the stomach reduces the extent of energy transfer between the emitting portions of the stomach and the like. The distance between the emitting portions having complementary emission spectra causes the energy transfer to occur to such an extent that both of the two portions emit zero and have a relative intensity such that the human eye perceives the light mixture as white light. , will receive white light emission. The case of an ion pair as described in the above examples can be extended to include more than two emission species. For the performance of the present invention, it is advantageous to select the emission portions constituting the wrong salt in such a manner that their emission spectra are complementary, that is, when each of the emission portions emits light of sufficient intensity, their emission spectra are covered. A sufficiently large portion of the visible spectrum is produced to produce white light emission. A sufficient amount of the intensities can be satisfied by adjusting the distance between the emitting portions, such as by adjusting the polarity of a surrounding substrate as described above. The appropriate distance between these parts depends on the nature of the selected part. This distance can be determined by those skilled in the art using the guidance provided in this application. For white light emission, although there is an ideal distance range between the emitted portions for each type of fault salt, too large a distance usually results in a small deviation from white light and too small a distance usually results in self-white light. More deviations (light is easily red-shifted when the distance between these parts is too small). Preferably, 'Μ, and M2 are both metal complexes. The main advantage of this embodiment is to ensure phosphorescence from the two parts of the wrong salt. Pure -17-201041999 organic molecules (in this case, the opposite of metal complexes) are usually fluorescent. If carrier recombination occurs on the organic molecule and no energy transfer occurs, this may result in a loss of efficiency. Another advantage is the simplicity of obtaining a charged emitter by using a metal complex. Finally, the charge in these complexes is usually internal, ie the charged metal ion has been surrounded by multiple ligands, especially in the case of octahedral complexes, but in organic molecules' The charge is usually at the periphery because they are derived from the grafting of charged substituents. Since electrostatic attraction is highly dependent on the distance between charges, a stronger interaction is expected when using organic molecules, which requires separation of more polar polymers or stronger electric fields for white light emission. Examples of suitable metals (4) or M2 are luminescent, charged, complexes of silver, ruthenium, money, osmium, uranium, gold, hungry, zinc, cadmium, mercury, copper or silver. A preferred metallic enthalpy!* Mz is a luminescent, charged complex of yttrium, lanthanum, cerium, lanthanum, platinum, gold, or hungry. Examples of electron-emitting cations are shown below: -18- 201041999

19- 20104199919- 201041999

-20 - 201041999-20 - 201041999

其中R1至R6係如以下Ri-R42和R63-R66中任一個所定義 的取代基。 較佳的是使用如上所定義的一錯鹽,其中: -21 - 201041999 1)M,表示 D(X)2(Y)2 或 D(X)2Z,其中 D代表選自以下的一種金屬離子:Ir、Ru、Os以及Wherein R1 to R6 are a substituent as defined in any one of the following Ri-R42 and R63-R66. It is preferred to use a wrong salt as defined above, wherein: -21 - 201041999 1) M, representing D(X)2(Y)2 or D(X)2Z, wherein D represents a metal ion selected from the group consisting of :Ir, Ru, Os, and

Rh ; 每個x彼此獨立地代表一種具有以下通式的化合物i 或I a, R 3Rh ; each x independently of each other represents a compound i or I a, R 3 having the following general formula

I R3I R3

由此具有通式I的多個化合物藉由一 sp2混成的碳原 子以及一 s p2混成的氮原子與D配位,並且具有通式I a的 多個化合物藉由兩個sp2混成的氮原子與D配位; 其中R】表示選自以下的一個部分:F、C1、-Ο-烷基 、-C( = 0)-0-烷基、-C( = 0)-CF3、-CF3、-CN、烷基以及 Η » 或者 R1 和 R2 — 起代表- CH = CH-CH = CH-; R2表示選自以下的一個部分:烷基、F、Cl、Br 、-C( = 0)-0-烷基、-C( = 0)-CF3、-CF3' -CN、烷基以及 Η , 或者 R2 和 R3 — 起代表-CH = CH-CH = CH-; R3表示選自以下的一個部分:-C(=〇)-〇-烷基、Η、-C( = 0)-CF3 、-CF3、-CN、烷基、-0-烷基、-N(烷基)2以及-N + (烷基)3 -22 - 201041999 或者 R3fD R4〆起代表-CH = CH-CH = CH-; R4表示選自以下的一*個部分· _C (=0)-0·院基、-C( = 0)-CF3 、-〇·烷基、烷基、H、F、C1以及Βγ ; 或者R4和R5 一起代表-CH = CH-; R5表示選自以下的一個部分:-c(=0)_0-院基、-C(=0)-CF3 、-Ο-烷基、烷基、H、F、C1以及Br; 或者 R5 和 R6 —起代表-CH=CH_CH=CH-或-CH2-CH=CH-CH2 ; R6表示選自以下的一個部分:Η、院基、院基、苯 基、-C( = 0)-0 -院基、-CF3、-C( = 0)-CF3、-CN、-Ν(烷基)2 以及-N + (烷基)3 ; 或者 R6 和 R7 —起代表-CH=CH-CH=CH-或-CH2-CH=CH-CH2- , R7表示選自以下的一個部分:H、F、C1、Br、_CN 、-CF3、-〇_烷基、烷基、-C( = 0)-0-烷基以及-C( = 0)-CF3 » 或者 R7 和 R8 —起代表-CH3 = CH-CH = CH-; 並且R8表示選自以下的一個部分:-CN、-CF3、-C( = 〇)-CF3 、-C( = 0)-0-烷基、Ο-烷基、烷基、H、F、ci以及Br; 每個Y彼此獨立地代表選自以下的一個部分:F、C1 、:Br、CH3.-0-院基、OH、-CN、-OCN 以及- SCN; 並且Z代表一種具有通式11或Ha的化合物’ -23- 11201041999Thus, a plurality of compounds of the formula I are coordinated to D by a carbon atom mixed with sp2 and a nitrogen atom of a s p2 mixture, and a plurality of compounds of the formula Ia are nitrogen atoms mixed by two sp2 Coordination with D; wherein R] represents a moiety selected from the group consisting of F, C1, -Ο-alkyl, -C(=0)-0-alkyl, -C(=0)-CF3, -CF3, -CN, alkyl and hydrazine » or R1 and R2 - represent - CH = CH-CH = CH-; R2 represents a moiety selected from the group consisting of alkyl, F, Cl, Br, -C( = 0)- 0-alkyl, -C(=0)-CF3, -CF3'-CN, alkyl and Η, or R2 and R3 - represent -CH = CH-CH = CH-; R3 represents a moiety selected from the following :-C(=〇)-〇-alkyl, hydrazine, -C(=0)-CF3, -CF3, -CN, alkyl,-0-alkyl, -N(alkyl)2, and -N + (alkyl) 3 -22 - 201041999 or R3fD R4 代表 represents -CH = CH-CH = CH-; R4 represents a * part selected from the following · _C (=0)-0 · yard base, -C ( = 0) -CF3, -〇.alkyl, alkyl, H, F, C1 and Βγ; or R4 and R5 together represent -CH=CH-; R5 represents a moiety selected from the group consisting of -c(=0) _0-院基,-C(=0)-C F3, -Ο-alkyl, alkyl, H, F, C1 and Br; or R5 and R6 together represent -CH=CH_CH=CH- or -CH2-CH=CH-CH2; R6 represents a one selected from the group below Part: Η, 院, 院, phenyl, -C( = 0)-0 -院, -CF3, -C( = 0)-CF3, -CN, -Ν(alkyl)2, and -N + (alkyl)3; or R6 and R7 together represent -CH=CH-CH=CH- or -CH2-CH=CH-CH2-, and R7 represents a moiety selected from the group consisting of H, F, C1, Br , _CN , -CF3, -〇_alkyl, alkyl, -C( = 0)-0-alkyl, and -C( = 0)-CF3 » or R7 and R8 together represent -CH3 = CH-CH = CH-; and R8 represents a moiety selected from the group consisting of -CN, -CF3, -C(= 〇)-CF3, -C(=0)-0-alkyl, Ο-alkyl, alkyl, H, F, ci, and Br; each Y independently represents a moiety selected from the group consisting of F, C1, :Br, CH3.-0-hospital, OH, -CN, -OCN, and -SCN; and Z represents a a compound having the formula 11 or Ha '-23- 11201041999

FTFT

RR

R 10R 10

R 12R 12

Ila, 其中 R9、R1Q、RM和R12彼此獨立地各自代表選自以下的 一個部分:-C( = 0)-0-烷基、烷基、苯基、Η、-N(烷基)2、 F、Cl、Br、-〇-院基以及-CF3 ; 並且由此具有通式Π或Ila的多個化合物藉由兩個 sp2混成的氮原子與D配位; 或 2)Μι表示FTL,其中 F代表選自以下的一種金屬離子· Pt和Au ; τ代表一種具有以下通式III、1113或IIIb的化合物Ila, wherein R9, R1Q, RM and R12 each independently represent a moiety selected from the group consisting of -C(=0)-0-alkyl, alkyl, phenyl, fluorene, -N(alkyl)2. F, Cl, Br, -〇-hospital and -CF3; and thus a plurality of compounds of the formula I or Ila are coordinated to D by a nitrogen atom mixed by two sp2; or 2) Μι denotes an FTL, wherein F represents a metal ion selected from the group consisting of Pt and Au; τ represents a compound having the following formula III, 1113 or IIIb

R 29 RR 29 R

30 Ilia30 Ilia

由此具有通式Ilia和Illb的多個化合物藉由一 sp2混 成的碳原子以及兩個s P2混成的氮原子與F配位,並且具 有通式111的多個化合物藉由三個s p2混成的氮原子與F -24- 201041999 配位; 其中 R25、R26、R27、R28、R29、R30、R31、R32 和 R33 彼此 獨立地各自代表選自以下的一部分:F、Cl、-CN、-C( = 0)-0-烷 基、烷基、-O-烷基、苯基、H、·Ν(院基)2以及-CF3 ; 並且L·代表選自以下的一配位基:C〇、_N(垸基)2、-NH2( 烷基)、F、Cl、Br、I、CN、0CN、-〇-烷基、-〇H 以及 SCN ; 或 表示G(U)2,其中 G代表選自以下的一種金屬離子:Ir、Ru、〇s以及Thus, a plurality of compounds having the formulas Ilia and 111b are coordinated to F by a carbon atom mixed with sp2 and a nitrogen atom of two s P2, and a plurality of compounds having the formula 111 are mixed by three s p2 The nitrogen atom is coordinated to F-24-201041999; wherein R25, R26, R27, R28, R29, R30, R31, R32 and R33 each independently represent a part selected from the group consisting of F, Cl, -CN, -C (= 0)-0-alkyl, alkyl, -O-alkyl, phenyl, H, Ν (hospital) 2 and -CF3; and L· represents a ligand selected from the group consisting of: C〇 , _N(fluorenyl) 2, -NH2(alkyl), F, Cl, Br, I, CN, 0CN, -〇-alkyl, -〇H, and SCN; or G(U)2, where G represents a metal ion selected from the group consisting of Ir, Ru, 〇s, and

Rh ; 每個X彼此獨立地代表一種具有通式1v、IVa* ivb 的化合物,Rh ; each X independently of each other represents a compound having the formula 1v, IVa* ivb,

由此具有通式IVa和iVb的多個化合物藉由一 sp2混 成的碳原子以及兩個sp2混成的氮原子與G配位,並且具 有通式IV的多個化合物藉由三個sp2混成的氮原子與G 配位; 其中 R34、R35、R36、' R3S、R39、R4。、R41 和 R42 -25- 201041999 彼此獨立地各自代表-Ο-烷基、F、Cl、-CN、-C( = 0)-0-烷 基、烷基、苯基、Η、-N(烷基)2和以及-CF3;或者 表示一種具有通式CuP2的化合物, 其中每個P彼此獨立地代表一種具有通式IX或X的 化合物,Thus, a plurality of compounds of the formulae IVa and iVb are coordinated to G by a sp2 mixed carbon atom and two sp2 mixed nitrogen atoms, and a plurality of compounds of the general formula IV are mixed by three sp2 nitrogens. The atom coordinates with G; where R34, R35, R36, 'R3S, R39, R4. , R41 and R42 -25- 201041999 each independently represent -Ο-alkyl, F, Cl, -CN, -C(=0)-0-alkyl, alkyl, phenyl, fluorene, -N (alkane) And 2) and -CF3; or a compound having the formula CuP2, wherein each P independently represents a compound of the formula IX or X,

其中R63、R64、R65和R66彼此獨立地各自代表選自 以下的一個部分:F、Cl、-CN、-C( = 0)-0-烷基、烷基、-0-烷基、苯基、Η、-N(烷基)2以及-CF3 ; 由此具有通式IX和X的多個化合物藉由兩個sp2混 成的氮原子與Cu配位; 和/或 5)M2表示E(W)2S,其中 E代表選自以下的一種金屬離子:Ir、Ru、Os以及Wherein R63, R64, R65 and R66 each independently represent a moiety selected from the group consisting of F, Cl, -CN, -C(=0)-0-alkyl, alkyl,-0-alkyl, phenyl , hydrazine, -N(alkyl) 2 and -CF3 ; thus a plurality of compounds of the formula IX and X are coordinated to Cu by a nitrogen atom in which two sp2 are mixed; and/or 5) M2 represents E (W) 2S, wherein E represents a metal ion selected from the group consisting of Ir, Ru, Os, and

Rh ; 每個W彼此獨立地代表一種具有通式Γ或la'的化合 物, -26- 18 15201041999 R 15Rh ; each W independently of one another represents a compound of the formula la or la', -26- 18 15201041999 R 15

R 18 R 19 ΓR 18 R 19 Γ

RR

R R 19 RR R 19 R

Ia', 由此具有通式Γ的多個化合物藉由一sp2混成的碳原 子以及一Sp2混成的氮原子與E配位,並且具有通式la,的 多個化合物藉由兩個sp2混成的氮原子與E配位; 其中R13表示選自以下的一個部分:F、C1、-Ο -烷基 、-C( = 0)'〇-烷基、-C( = 〇)-CF3、-CF3、-CN、烷基以及 Η » 或者 和 ri4 一 起代表-ch = CH-CH = CH-; R14表示選自以下的一個部分:-c( = o)-o-烷基、-(:(=〇)-€?3-、-CF3、-CN、-0-院基、F、Cl、Br 以及 H; 或者 R14 和 R15 — 起代表-CH = CH-CH = CH-; r15表示選自以下的一個部分\c(=0)-0-垸基、H、-c(=0)-cf3 、-CF3、-CN、烷基、-〇-烷基、-N(烷基1)2以及-N + (烷基 )3 ; 或者R15和R16〆起代表-CH = CH-CH = CH·; R“表示選自以下的一個部分:Η、F、CM、-CN、-CF3、 烷基、-〇-烷基以及W ; 或者R16和R17^起代表_CH = CH_’Ia', whereby a plurality of compounds of the formula 配 are coordinated with E by a sp2 mixed carbon atom and a Sp2 mixed nitrogen atom, and a plurality of compounds having the formula la are mixed by two sp2 The nitrogen atom is coordinated to E; wherein R13 represents a moiety selected from the group consisting of F, C1, -Ο-alkyl, -C(=0)'〇-alkyl, -C(=〇)-CF3, -CF3 , -CN, alkyl and hydrazine » or together with ri4 represent -ch = CH-CH = CH-; R14 represents a moiety selected from the group consisting of -c( = o)-o-alkyl, -(:(= 〇)-€?3-, -CF3, -CN, -0-hospital, F, Cl, Br and H; or R14 and R15 - represent -CH = CH-CH = CH-; r15 means selected from the following a part of \c(=0)-0-mercapto, H, -c(=0)-cf3, -CF3, -CN, alkyl, -〇-alkyl, -N(alkyl 1)2 and -N + (alkyl) 3 ; or R 15 and R 16 are represented by -CH = CH-CH = CH·; R " represents a moiety selected from the group consisting of hydrazine, F, CM, -CN, -CF3, alkyl , -〇-alkyl and W; or R16 and R17^ represent _CH = CH_'

R17表示選自以下的一個部分:Η、-Ο-烷基、烷基、-CN ,-CF3、F、C1 以及 Μ ; -27- 201041999 或者 R17 和 R1S —起代表-CH=CH-CH=CH-或·CH2_CH=CH-CH2- R18表示選自以下的一個部分:Η、院基、-〇 -院基、 苯基、-c( = o)-o-烷基、 -CF3、-C( = 0)-CF3 ' -CN、-N(烷基 )2以及-N + (烷基)3 ; 或者 R18 和 R19 —起代表-CH=CH-CH=CH-或-CH2-CH=CH-CH2- R19表示選自以下的—個部分:Η、-Ο-烷基、烷基、-CN 、-CF3、-C( = 〇)-CF3、F、Cl 以及 Br ; 或者 R19 和 R2G — 起代表- CH = CH-CH = CH-; 並且R2Q表示選自以下的一個部分:-Ο-烷基 '烷基 、-CN、-CF3' -C( = 0)-CF3、F、C1 以及 Br; 並且S代表一種具有通式ΙΓ或Ila’的化合物,R17 represents a moiety selected from the group consisting of hydrazine, -Ο-alkyl, alkyl, -CN, -CF3, F, C1 and hydrazine; -27- 201041999 or R17 and R1S together represent -CH=CH-CH= CH- or ·CH2_CH=CH-CH2- R18 represents a moiety selected from the group consisting of fluorene, fenium, fluorene-terminated, phenyl, -c(=o)-o-alkyl, -CF3, -C ( = 0)-CF3 '-CN, -N(alkyl)2 and -N + (alkyl)3; or R18 and R19 together represent -CH=CH-CH=CH- or -CH2-CH=CH -CH2-R19 represents a moiety selected from the group consisting of hydrazine, -Ο-alkyl, alkyl, -CN, -CF3, -C(= 〇)-CF3, F, Cl, and Br; or R19 and R2G- Represents - CH = CH-CH = CH-; and R2Q represents a moiety selected from the group consisting of -Ο-alkyl'alkyl, -CN, -CF3' -C( = 0)-CF3, F, C1 and Br; and S represents a compound having the formula I or Ila',

其中R21、R22 ' R23和R24彼此獨立地各自代表選自 以下的一個部分:Η、-C( = 0)-〇-烷基、烷基、_〇_烷基、_CN 、苯基、Η、-N(烷基)2以及- CF3。 假如任何在此所定義的化學式中的任何一個部分代表 苯基,則所述本基係未取代的或被一或多個取代基所取代 -28- 201041999 的’較佳的是未取代的或可隨意地被1'2、3、4或5個 取代基所取代的。所述一或多個取代基可獨立地優先選自 :甲基、乙基、正丙基、異丙基、正丁基、叔丁基、仲丁基 、異 丁基 '正戊基、-〇-CH3、-o-c2h5、-〇-CH2-CH2-CH3 、-o-ch(ch3)2、-〇-C(CH3)3、-C( = 0)-0H、-c( = o)-o-ch3 、-c(=o)-〇-c2h5、-c(=o)-o-ch2-ch2-ch3、-c(=o)-o-ch(ch3)2 、-C( = 0)-〇-c(CH3)3、F、Cl、Br、I、-CN、-CF3、-0-CF3 、-s-cf3、-OH、-sh、-nh2、-nh-ch3、-nh-c2h5、-nh-ch2-ch2-ch2 、-nh-ch(ch3)2、-no2、-cho、-cf2h ' -cfh2、-c(o)-nh2 、-c( = o)-nh-ch3 以及- s( = o)2-ch3。 假如任何在此所定義的化學式中的任何一個部分代表 一個院基,較佳的是一 Cmq院基,更較佳的是一 Ci-5院 基’則所述烷基係未取代的或被一或多個取代基所取代的 ,較佳的是未取代的或可隨意地被1、2、3、4或5個取 代基所取代的。所述一或多個取代基可獨立地優先選自 :-o-ch3、-o-c2h5、-o-ch(ch3)2、-0-C(CH3)3、-CN、-cf3 、-0CF3、-SCF3、-OH、-SH、-NH2、-NH-CH3、-NH-C2H5 、-NH-CH2-CH2-CH3、-nh-ch(ch3)2、-nh-c(ch3)3、-n(ch3)2 以及-n(c2h5)2。 合適的烷基(可以被一或多個取代基所取代)可優先選 自:甲基、乙基、正丙基、異丙基、正丁基、異丁基、仲 丁基、叔丁基、正戊基以及新戊基。 在上述的該等化學式中,L較佳的是選自以下的的中 性的單齒配位基:一氧化碳(C0)、胺(NR3) '亞胺(RN = CR) -29 - 201041999 、吡啶、膦(PR3)、胂(AsR3)、腈(RCN)、異腈(RNC)、醚 (ROR)、二硫化物(RSR)以及聯砸化物(RSeR)。 在上述該等化學式中,L還可以是優先選自以下的一 種陰離子配位基:鹵化物(F·、cr、Br_、Γ)、假鹵化物 (CN-、OCN-、SCN-)、烷基陰離子(CH3-)、芳基陰離子(Ph-)、醇鹽(alk〇holate)(R(T)、硫醇鹽(RS·)以及氫氧化物(OH· )° 更佳的是使用一種金屬錯合物,其中 表示 D(X)2(Y)2 或 D(X)2Z,其中 D代表選自以下的一種金屬離子:Ir(III)、Ru(II)、 Os(II)以及 Rh(III); 每個X彼此獨立地代表一種具有通式I或la的化合Wherein R21, R22' R23 and R24 each independently represent a moiety selected from the group consisting of hydrazine, -C(=0)-oxime-alkyl, alkyl, 〇-alkyl, _CN, phenyl, fluorene, -N(alkyl)2 and -CF3. In the event that any one of the formulae defined herein represents a phenyl group, the radical is unsubstituted or substituted by one or more substituents. 28-201041999 is preferably unsubstituted or Optionally substituted with 1'2, 3, 4 or 5 substituents. The one or more substituents may be independently selected from the group consisting of: methyl, ethyl, n-propyl, isopropyl, n-butyl, t-butyl, sec-butyl, isobutyl 'n-pentyl, - 〇-CH3, -o-c2h5, -〇-CH2-CH2-CH3, -o-ch(ch3)2, -〇-C(CH3)3, -C( = 0)-0H, -c( = o )-o-ch3, -c(=o)-〇-c2h5, -c(=o)-o-ch2-ch2-ch3, -c(=o)-o-ch(ch3)2, -C( = 0)-〇-c(CH3)3, F, Cl, Br, I, -CN, -CF3, -0-CF3, -s-cf3, -OH, -sh, -nh2, -nh-ch3, -nh-c2h5, -nh-ch2-ch2-ch2, -nh-ch(ch3)2, -no2, -cho, -cf2h ' -cfh2, -c(o)-nh2, -c( = o)- Nh-ch3 and - s( = o)2-ch3. If any one of the formulae defined herein represents a hospital base, preferably a Cmq hospital base, more preferably a Ci-5 yard base 'the alkyl group is unsubstituted or Substituted by one or more substituents, it is preferably unsubstituted or optionally substituted by 1, 2, 3, 4 or 5 substituents. The one or more substituents may be independently selected from the group consisting of: -o-ch3, -o-c2h5, -o-ch(ch3)2, -0-C(CH3)3, -CN, -cf3, - 0CF3, -SCF3, -OH, -SH, -NH2, -NH-CH3, -NH-C2H5, -NH-CH2-CH2-CH3, -nh-ch(ch3)2, -nh-c(ch3)3 , -n(ch3)2 and -n(c2h5)2. A suitable alkyl group (which may be substituted by one or more substituents) may be preferably selected from the group consisting of methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl , n-pentyl and neopentyl. In the above chemical formulas, L is preferably a neutral monodentate ligand selected from the group consisting of carbon monoxide (C0), amine (NR3) 'imine (RN = CR) -29 - 201041999, and pyridine. , phosphine (PR3), hydrazine (AsR3), nitrile (RCN), isonitrile (RNC), ether (ROR), disulfide (RSR), and hydrazine (RSeR). In the above chemical formulas, L may also be an anionic ligand preferably selected from the group consisting of halides (F·, cr, Br_, Γ), pseudohalides (CN-, OCN-, SCN-), alkanes. a base anion (CH3-), an aryl anion (Ph-), an alkoxide (alk〇holate) (R(T), a thiolate (RS·), and a hydroxide (OH·)°, more preferably a type a metal complex, wherein D(X)2(Y)2 or D(X)2Z, wherein D represents a metal ion selected from the group consisting of Ir(III), Ru(II), Os(II), and Rh (III); each X independently represents a compound having the formula I or la

由此具有通式I的多個化合物藉由一 SP2混成的碳原 子以及一 sp2混成的氮原子與D配位’並且具有通式la的 多個化合物藉由兩個sp2混成的氮原子與D配位; 其中R1表示選自以下的一個部分:-C( = 〇)-〇-烷基、-C( = 0)-CF3、-CF3、-CN' 烷基以及 H; 201041999 R2表不選自以下的一個部分:-〇 -院基、F、Cl、Br 以及Η ; 或者 R2 和 R3 —起代表-CH = CH-CH = CH-; R3表示選自以下的一個部分:-C( = 0)-0-烷基、Η、-C( = 0)-CF3 、-CF3、-CN、烷基、-Ο-烷基、-N(烷基)2以及-N + (烷基)3 或者 R3 和 R4 — 起代表-CH = CH-CH = CH-; R4表示選自以下的一個部分:Η、F、Cl以及Br ; 或者R4和R5 —起代表- CH = CH-; R5表示選自以下的一個部分:Η、F、Cl以及Br ; 或者 R5 和 R6 —起代表-CH=CH-CH=CH-或-CH2-CH=CH-CH2- » R6表示選自以下的一個部分:Η、烷基、-Ο-烷基、苯 基、-C( = 0)-0-烷基、-CF3、-C( = 0)-CF3、-CN、-Ν(烷基)2 以及-N + (烷基)3 ; 或者 R6 和 R7 —起代表-CH = CH-CH = CH-或-CH2-CH=CH-CH2- > R7表示選自以下的一個部分:Η、F、Cl以及Br ; 或者 R7 和 R8 — 起代表-CH = CH-CH = CH-; 並且R8表示選自以下的一個部分:Η、F、Cl以及Br t 每個Y彼此獨立地代表選自以下的一個部分:-CN、-OCN 以及-S C N ; 並且Z代表一種具有通式II或Ila的化合物, -31 - 201041999 R9Thus, a plurality of compounds of the formula I are coordinated to the D by a carbon atom mixed with SP2 and a nitrogen atom of a sp2 and have a plurality of compounds of the formula la and a nitrogen atom mixed with two sp2 Coordination; wherein R1 represents a moiety selected from the group consisting of -C(= 〇)-〇-alkyl, -C(=0)-CF3, -CF3, -CN' alkyl and H; 201041999 R2 is not selected From one of the following: -〇-院, F, Cl, Br, and Η; or R2 and R3 together represent -CH = CH-CH = CH-; R3 represents a part selected from the following: -C( = 0)-0-alkyl, hydrazine, -C(=0)-CF3, -CF3, -CN, alkyl, -Ο-alkyl, -N(alkyl)2, and -N + (alkyl)3 Or R3 and R4 together represent -CH = CH-CH = CH-; R4 represents a moiety selected from the group consisting of Η, F, Cl, and Br; or R4 and R5 together represent - CH = CH-; R5 indicates From one of the following: Η, F, Cl, and Br; or R5 and R6 together represent -CH=CH-CH=CH- or -CH2-CH=CH-CH2- » R6 represents a moiety selected from the following: Η, alkyl, -Ο-alkyl, phenyl, -C(=0)-0-alkyl, -CF3, -C(=0)-CF3, -CN, -Ν(alkyl 2 and -N + (alkyl) 3 ; or R 6 and R 7 together represent -CH = CH-CH = CH- or -CH2-CH=CH-CH2- > R7 represents a moiety selected from the group consisting of: F, Cl and Br; or R7 and R8 together represent -CH = CH-CH = CH-; and R8 represents a moiety selected from the group consisting of Η, F, Cl and Br t each Y independently of each other One of the following: -CN, -OCN, and -SCN; and Z represents a compound of Formula II or Ila, -31 - 201041999 R9

其中 R9、R1。、R11和R12彼此獨立地各自代表選自以下的 一個部分:-C( = 〇)-〇_烷基、烷基、苯基、H、-N(烷基)2、 以及-CF3 ; 並且由此具有通式11和IIa的多個化合物藉由兩個 Sp2混成的氮原子與D配位; 或 2)Μι表示FTL’其中 F代表選自一種選自以下的金屬離子:Pt(U)、Au(I) 以及 Au(III); T代表一種具有通式ΙΠ、Ilia或Illb的化合物Where R9, R1. And R11 and R12 each independently represent a moiety selected from the group consisting of -C(= 〇)-〇-alkyl, alkyl, phenyl, H, -N(alkyl) 2, and -CF3; The plurality of compounds having the formulae 11 and IIa are coordinated to D by a nitrogen atom in which two Sp2 are mixed; or 2) Μι denotes FTL' wherein F represents a metal ion selected from the group consisting of Pt(U), Au(I) and Au(III); T represents a compound of the formula ΙΠ, Ilia or Illb

III IliaIII Ilia

由此具有通式Ilia和Illb的多個化合物藉由一 sp2混 成的碳原子以及兩個sp2混成的氮原子與F配位,並且具 -32- 201041999 有通式III的多個化合物藉由三個sp2混成的氮原子與F 配位; 其中 R25 、 R26 、 R27 、 R28 、 r29 、 r3〇 、 r31 、 R32 和 r33 彼此獨立地各自代表選自以下的一個部分:F、C1、_CN 、-C( = 0)-0-烷基、烷基、苯基、Η、-N(烷基)2以及·cf3 並且L代表選自以下的一配位基:CO、-NH(烷基)2 、-NH2(院基)、F、Cl、Br、I、-CN' OCN 以及 SCN; 或 3)M!表不G(U)2,其中 G代表選自以下的一種金屬離子:ir(III)、Ru(II)、 Os(II)以及 Rh(III); 每個U彼此獨立地代表—種具有通式IV、IVa或IVb 的化合物,Thus, a plurality of compounds having the formulas Ilia and 111b are coordinated to F by a sp2 mixed carbon atom and two sp2 mixed nitrogen atoms, and have a plurality of compounds of the general formula III by -32-201041999 The sp2 mixed nitrogen atoms are coordinated to F; wherein R25, R26, R27, R28, r29, r3〇, r31, R32 and r33 each independently represent a moiety selected from the group consisting of F, C1, _CN, -C (= 0)-0-alkyl, alkyl, phenyl, fluorene, -N(alkyl) 2 and · cf3 and L represents a ligand selected from the group consisting of CO, -NH(alkyl) 2 , -NH2 (hospital), F, Cl, Br, I, -CN' OCN and SCN; or 3) M! represents G(U)2, where G represents a metal ion selected from the group consisting of ir(III) , Ru(II), Os(II), and Rh(III); each U independently of each other represents a compound having the formula IV, IVa or IVb,

由此具有通式IVa和iVb的多個化合物藉由一 sp2混 成的碳原子以及兩個sp2混成的氮原子與g配位,並且具 有通式IV的多個化合物藉由三個sP2混成的氮原子與G 配位; -33- 201041999Thus, a plurality of compounds of the formulae IVa and iVb are coordinated to g by a sp2 mixed carbon atom and two sp2 mixed nitrogen atoms, and a plurality of compounds of the formula IV are mixed by three sP2 Atomic coordination with G; -33- 201041999

其中R 3 4Where R 3 4

R35、R36、R 3 7R35, R36, R 3 7

R 3 8R 3 8

R 3 9R 3 9

R 40R 40

R41 和 R 42 個部分:Η、F、Cl、-CN Η、-Ν(院基)2以及- CF3 彼此獨立地各自代表選自以下@ 、-c( = o)-o-烷基、烷基 '苯棊 和/或 4)Μ2表示E(W)2S,其中 E代表選自以下的一種金屬離子· ΐΓ(ΠΙ)、RU(II)、 Os(II)以及 Rh(III); 每個w彼此獨立地代表一種具有通式r或1a'的化合 物, R 1542 parts of R41 and R: Η, F, Cl, -CN Η, -Ν (hospital) 2 and - CF3 are each independently represented by the following @, -c( = o)-o-alkyl, alkane The base 'benzoquinone and/or 4) Μ2 represents E(W)2S, wherein E represents a metal ion selected from the group consisting of ruthenium (ΠΙ), RU(II), Os(II), and Rh(III); w independently of each other represents a compound of the formula r or 1a', R 15

R 18 R 19 R R 15R 18 R 19 R R 15

R 18 R 19 RR 18 R 19 R

Ia,, 由此具有通式Γ的多個化合物藉由—Sp2混成的碳原 子以及一 sp2混成的氮原子與E配位,並且具有通式la’的 多個化合物藉由兩個sp2混成的氮原子與E配位; 其中R13表示選自以下的一個部分:-C( = 0)-〇 -烷基 、-C( = 0)-CF3、-CF3、-CN、烷基以及 Η ; R14表示選自以下的一個部分:烷基、F、Cl、Br 以及Η ; 或者 R14 和 R15 — 起代表-CH = CH-CH = CH-; -34- 201041999 R15表示選自以下的一個部分:-C(=0)-0-烷基、Η、-C(=〇)-CF3 、-CF3、-CN、烷基、-Ο-烷基、-N(烷基)2以及- N + (烷基)3 或者 R15 和 R16 — 起代表- CH = CH-CH = CH-; R16表示選自以下的一個部分:Η、F、Cl以及Br ; 或者R16和R17 —起代表- CH = CH-; R17表示選自以下的一個部分:Η、F、Cl以及Br ; 或者 R17 和 R18 —起代表-CH=CH-CH=CH-或-CH2-CH=CH-CH2- » R18表示選自以下的一個部分:Η、烷基、-Ο-烷基、 苯基、·(:( = 0)-0-烷基、-CF3、-C( = 0)-CF3、-CN、-Ν(烷基 h以及-N + (烷基)3 ; 或者 R18 和 R19 —起代表-CH=CH-CH=CH-或-CH2-CH=CH-CH2- R19表示選自以下的一個部分:Η、F、Cl以及Br ; 或者 R19 和 R2° — 起代表- CH = CH-CH = CH-; 並且R2()表示選自以下的一個部分:Η、F、Cl以及Ia, the plurality of compounds having the general formula 配 are coordinated with E by a carbon atom mixed with -Sp2 and a nitrogen atom mixed with sp2, and a plurality of compounds having the general formula la' are mixed by two sp2 The nitrogen atom is coordinated to E; wherein R13 represents a moiety selected from the group consisting of -C(=0)-〇-alkyl, -C(=0)-CF3, -CF3, -CN, alkyl and hydrazine; R14 Represents a moiety selected from the group consisting of alkyl, F, Cl, Br, and deuterium; or R14 and R15 together represent -CH = CH-CH = CH-; -34- 201041999 R15 represents a moiety selected from the group consisting of - C(=0)-0-alkyl, hydrazine, -C(=〇)-CF3, -CF3, -CN, alkyl, -Ο-alkyl, -N(alkyl)2, and -N + (alkane Base) 3 or R15 and R16 - represent - CH = CH-CH = CH-; R16 represents a moiety selected from the group consisting of Η, F, Cl, and Br; or R16 and R17 together represent - CH = CH-; R17 represents a moiety selected from the group consisting of ruthenium, F, Cl, and Br; or R17 and R18 together represent -CH=CH-CH=CH- or -CH2-CH=CH-CH2-» R18 represents a selected from One part: hydrazine, alkyl, -Ο-alkyl, phenyl, ·(:( = 0)-0-alkyl, -CF3 -C( = 0)-CF3, -CN, -Ν(alkyl h and -N + (alkyl) 3 ; or R18 and R19 together represent -CH=CH-CH=CH- or -CH2-CH= CH-CH2-R19 represents a moiety selected from the group consisting of ruthenium, F, Cl, and Br; or R19 and R2° - representing - CH = CH-CH = CH-; and R2() represents a moiety selected from the group consisting of :Η, F, Cl, and

Br ; 並且S代表一種具有通式II'或Ila'的化合物,Br ; and S represents a compound having the general formula II' or Ila',

II Ila' ’ -35- 201041999 其中 R21、R·22、R23和R24彼此獨立地各自代表選自 一個部分:H、-C( = 0)-0-院基、院基、苯基、η、-)2、以及-CF3。 在另一實施方式中,和[Μ2η·]中的一個 發射性的有機的非金屬的離子。較佳的是,該發射 機非金屬離子係一小分子或一具有最多10個重複 低聚物,即,不是一聚合物。 該等發射性有機非金屬離子的實例係被離子的 取代的發射性有機非金屬分子。 發射性有機非金屬離子的非限制性實例係蒽、 '酞菁、咕噸、二萘嵌苯、芘、紅熒烯、香豆素、 瑰精、紫菜城、咕啉、喹啉、喹吖啶酮、二氰基亞 喃、花青 '偶氮染料、羰基染料、聚烯、聚甲炔、 吡喃鑰、噻喃鎗、芴、低聚芴、茚並芴、低聚茚 periflanthene、節並、二(曝基)胺硼、二(曉基)甲 光黃素、喹諾酮、蒽醌以及硼酸鹽的離子的衍生物 予那些發射性的有機非金屬分子的衍生物一離子特 代基係例如S〇3_、S04-、COCT、-NR3+,其中每個 立地代表例如C,-C6-烷基或c5-c1Q-芳基。一寬的 發射顏色可以藉由此類衍生物在取代模式的作用下 紅光發射的有機非金屬陽離子μ !的族的一非 實例係根據以下化學式V的二萘嵌苯衍生物’ 以下的 Ν(烷基 可以是 性的有 單元的 基團所 並四苯 鹼性玫 甲基吡 噻喃、 並荀、 烷、螢 。能給 徵的取 R可獨 變化的 獲得。 限制性 -36- 201041999 R48II Ila' '-35- 201041999 wherein R21, R·22, R23 and R24 are each independently selected from one part: H, -C(=0)-0-hospital, yard, phenyl, η, -) 2, and -CF3. In another embodiment, and one of [Μ2η·] emits an organic non-metallic ion. Preferably, the emitter is a small molecule or a polymer having up to 10 repeating oligomers, i.e., not a polymer. Examples of such emissive organic non-metal ions are ion-substituted emissive organic non-metal molecules. Non-limiting examples of emissive organic non-metal ions are 蒽, 'phthalocyanine, xanthene, perylene, fluorene, rubrene, coumarin, rose, laver, porphyrin, quinoline, quinoline Pyridone, dicyanofuran, cyanine 'azo dye, carbonyl dye, polyene, polymethine, pyran, thiopyran, anthraquinone, oligosaccharide, fluorene, fluorene periflanthene, Derivatives of ionic ions of bis(exo)amine boron, bis(methylene) ketone, quinolone, oxime and borate to derivatives of ionic organic nonmetal molecules For example, S〇3_, S04-, COCT, -NR3+, wherein each of the sites represents, for example, C,-C6-alkyl or c5-c1Q-aryl. A wide emission color can be a non-example of a family of organic non-metal cations that emit red light by the substitution mode under the action of a substitution mode. According to the perylene derivative of the following chemical formula V' (Alkyl may be a linear unitary group of tetracene basic methicillin, hydrazine, alkane, fluoran. The R can be obtained by a single change. Restricted -36- 201041999 R48

V, ❹ 其中 R43 和 R :甲基、乙基 戊基; 並且R45 以下的一個部 一具體的 〇 Μ彼此獨立地各自表示選自以下的一 、正丙基、異丙基、正丁基、叔丁基 、R46、R47和R48彼此獨立地各自表 分:Η、甲基、-0 -甲基、F、C1和Br 實例係 個部分 以及正 二p s'EB r±3 不进目 紅光發射V, ❹ wherein R43 and R are methyl, ethylpentyl; and one part of R45 below a specific oxime independently of each other represents a selected from the group consisting of n-propyl, isopropyl, n-butyl, Tert-butyl, R46, R47 and R48 are each independently distinguished from each other: Η, methyl,-0-methyl, F, C1 and Br, part of the example, and n-p s'EB r±3 emission

的有機非金屬陰離子M2的族的一非 限制性 -37- 201041999 實例係根據以下化學式VI的二萘嵌苯衍生物 R49A non-limiting family of organic non-metallic anions M2 -37- 201041999 Examples are perylene derivatives according to the following chemical formula VI R49

其中R49、R5Q、R51和R52彼此獨立地各自表示選自 以下的一個部分:H、甲基、-Ο -甲基、F、C1以及Br; 一具體的實例係Wherein R49, R5Q, R51 and R52 each independently represent a moiety selected from the group consisting of H, methyl, -Ο-methyl, F, C1 and Br;

藍光發射的有機非金屬陽離子Μ >的族的一非限制性 實例係根據以下式VII的芴衍生物: -38- 201041999A non-limiting example of a family of blue-emitting organic non-metallic cations > is an anthracene derivative according to formula VII below: -38- 201041999

VII, 其中 R53、R54、R55、R56、R57 和 R58 可表示選自以下的一個部分:H、甲基、 異丙基、正丁基、叔丁基、正戊基; 並且R59和R6(>彼此獨立地各自可表 個部分:正戊基、新戊基、異戊基、正己 辛基或乙基己基(ethylexyl)。 一具體的實例係: 此獨立地各自 基、正丙基、 選自以下的一 、正庚基 '正VII, wherein R53, R54, R55, R56, R57 and R58 may represent a moiety selected from the group consisting of H, methyl, isopropyl, n-butyl, t-butyl, n-pentyl; and R59 and R6 (&gt Independently from each other, each part can be represented: n-pentyl, neopentyl, isopentyl, n-hexyl or ethylexyl. A specific example is: this independently, each, n-propyl, selected From the following one, positive

非限制性實例 藍光發射的有機非金屬陰離子M2的族的 係根據以下式ν Π Ϊ的芴衍生物: -39- 201041999 O' 〇=s=〇Non-limiting examples The family of blue-emitting organic non-metal anions M2 is based on the following formula ν Π Ϊ 芴 derivatives: -39- 201041999 O' 〇=s=〇

VIII, 其中R01和R62彼此獨立地各自可表示選自以下的一 個部分:正戊基、新戊基、異戊基、正己基、正庚基、正 辛基或乙基己基。 一具體的實例係: 0· / 〇=S=〇VIII, wherein R01 and R62, each independently of each other, represent a moiety selected from the group consisting of n-pentyl, neopentyl, isopentyl, n-hexyl, n-heptyl, n-octyl or ethylhexyl. A specific example is: 0· / 〇=S=〇

後面是根據本發明的實施方式的錯鹽的一些實例·’ -40 - 201041999The following are some examples of the wrong salt according to an embodiment of the invention. '-40 - 201041999

ο οο ο

-41 - 201041999-41 - 201041999

2 在本發明的第一方面的任何一個實施方式中’在該發 光材料的組成中可以包括一助黏附劑。這樣一助黏附劑係 本領域的熟習該項技術者所熟知的。當該發光材料用於塗 覆一底物(諸如一無機led管殻或一螢光燈的玻璃管)時, 這係特別有利的。 在一第二方面,本發明涉及用於製備根據本發明的第 一方面的發光材料並且特別是一錯鹽的方法。 在第二方面的一實施方式中’本發明係針對一種用於 製備在申請專利範圍第1至1 1項的任一項中所揭露的一 錯鹽的方法’其特徵在於:將至少一種具有通式[M,m + ]XA- -42- 201041999 的鹽與至少—種具有通式[M2„-]yC+的鹽可隨意地在至少一 種溶劑的存在下、在範圍在^力至5〇r (較佳的是在15〇c 至3 0 °c )之間的溫度下進行反應,以獲得一種具有通式 + 的金屬錯合物,其中仏係如申請專利範圍 第1至4項中的任一項所定義,並且A_表示選自以下的一 種陰離子:Cl、Br-、PF6·、BF4·和F·,其中M2係如以上 給定的定義’並且C表示選自以下的—種陽離子:Na+、 0 K+、Li +和NR/這裡每個R彼此獨立地表示η或烷基,該 金屬錯合物可隨意地被純化和/或被分離。較佳的是,C係 κ+,和/或該溶劑係一種選自以下組的極性的疏質子的溶 劑:甲醇、乙醇、水以及它們的混合物。 具有通式[Μ^+ΚΑ·以及具有通式[M2n-]yC +的多個化合 物的合成(除其他之外)在Μ. K. Nazeeruddin et al., Am. Chem. Soc. 2003, 1 25, 8790 and Μ. K. Nazeeruddin et al., Inorg_ Chem. 2007, 46,5989中進行了具體描述。該揭露 Q 內容的相應部分藉由引用結合在此。 在一第三方面,本發明涉及一種包括一發射層的發光 裝置,所述發射層包括或由一種根據本發明的第一方面的 發光材料所構成。 更佳的是,該發射層在300 nm至500 nm之間的波長 的激發下、或在穿過所述發射層施加一電壓時,能夠發射 出在(0.200,0.200)至(0.550,0.500)範圍內具有 CIE 1931 座標U,y)的光。 在多個實施方式中,該發光裝置係一有機的發光裝置 -43- 201041999 。一有機的發光裝置總的來說包括: •一底物(較佳的是一透明的底物), •一第一傳導層(較佳的是一透明的傳導層), •可隨意地,一或多個電洞傳輸和/或電洞注入和/或電子 阻擋層, •一或多個發射層, •可隨意地,一或多個電子傳輸和/或電子注入 '和/或電 洞阻擋層,以及 .一第二傳導層。 該底物可以由一種材料或由超過多種材料形成。該底 物可以是有機的或無機的,平面的或非平面的。合適的無 機底物的實例係玻璃和石英。合適的有機底物的實例係透 明的聚合物,諸如但不限於:聚(甲基丙烯酸甲酯)(PMMA) 以及聚碳酸酯。該底物可以是剛性的或柔性的。 該第一傳導層起到一陽極的作用。一典型的實例係氧 化錫銦(ITO)其他實例係摻雜有例如Sn或F的氧化錫。 用於電洞注入層(或電洞傳輸層或電子阻擋層)的可用 的材料係本領域的熟習該項技術者所熟知的並且包括例如 聚苯胺(“PANI”)、聚(3,4-乙烯二氧噻吩)(“PEDOT”)、聚吡 略、各種三芳基胺以及咔唑,諸如4,4'-雙[N-(萘基)-N-苯 基-胺基]聯苯(α-NPD)、Ν,Ν,-雙(3-甲基苯基)-Ν,Ν'-二苯 基-[1,1,-聯苯基]-4,4,二胺(TPD)、4,4,-雙[Ν-(2-萘基)-Ν-苯 基-胺基]聯苯(β-NPD)、4,4,,4"-三(3 -甲基苯基苯胺基)三苯 胺(MTDATA)、4,4’-Ν,Ν’-二咔唑-聯苯(CBP)、Ν , Ν ', Ν "- -44- 201041999 1,3,5-三咔唑苯(tCP)以及 4,4',4”-三(N-咔唑基)-三苯胺 (TCTA)。另外,可以使用P-摻雜,摻入電子受體,例如 像四硫富瓦烯四氰基醌二甲烷鹽(“丁丁?-代\(5,,)、2,3,5,6-四氟-7,7,8,8-四氰基二甲基苯醌(F4-TCNQ)、以及高逸出 功的金屬氧化物,諸如’除其他以外,氧化鉬、氧化釩、 以及氧化鎢。 該裝置可進一步包括在該發射層和該電洞傳輸層之間 的一電子阻擋層。當該發射層係一電子傳導層時,這個實 施方式是較佳的。 在本發明的多個實施方式中,該一或多個發射層較佳 的是一個單一的發射層’包括或由一種如在本發明的協力 廠商面所定義的發光材料所構成。 用於電子注入層(或電子傳輸層或電洞阻擋層)的可用 的材料係本領域的熟習該項技術者所熟知的並且包括··除 其他之外,例如一種金屬鼇合的oxinoid化合物(例如, Alq3 或銘(III)雙(2 -甲基-8 -喳琳)4-憐酸苯酯(aluminum(III)bis (2-methyl-8-quinolinato)4-phenylphenolate)(‘‘BAlq,’)); 一 種基於菲咯啉的化合物(例如,2,9 -二甲基-4,7·二苯基-1,10-菲咯啉(“DDPA”)或 9,10-二苯基蒽(“DPA”));一種唑 化合物(例如,2-叔丁基苯基-5-聯苯基-1,3,4-噁二唑 (“?80”)或3-(4-聯苯基)-4-苯基-5-(4-叔丁基苯基)-1,2,4-三唑(“ΤΑΖ”)); 一種二苯基蒽衍生物;一種二萘基蒽衍生 物、4,4 -雙(2,2-二苯基-乙烯-1-基)-聯苯(“DPVBI”); 9,10-二-β-萘基蒽;9,1〇-二-(萘基)蒽;9,10-二-(2-萘基)蒽 -45- 201041999 (“ADN”); 4,4f-雙(咔唑-9 基)聯苯(“CBP”): 9,10-雙-[4-(2,2-二苯基乙烯基)-苯基]-蒽(“80?¥?八”);蒽;1芳基苯 並咪唑(諸如“ΤΡΒΙ”); I,4·雙[2-(9-乙基-3-咔唑)乙烯基]苯 (l,4-bis[2-(9-ethyl-3-carbazoyl)vinylenyl]benzene) ; 4,4’- 雙[2-(9-乙基-3-咔唑基)乙烯基]-1,1'-聯苯(4,4'-1)丨8[2-(9-6七11;^1-3-。&1^37〇丫1)乂111)^611丫1]-1,1’-1)011611丫1);9,1〇-雙[2,2-(9,9-苟基)乙稀基]惠(9,10-bis[2,2-(9,9-fluorenylene) vinylenyl]anthracene) ; 1,4-雙[2,2-(9,9-荀基)乙嫌基]苯 (l,4-bis[2,2-(9,9-fluorenylene)vinylenyl]benzene) ; 4,4’- 雙[2,2-(9,9-芴基)乙烯基]-1,1'-聯苯(4,4'-1>丨3[2,2-(9,9-fluorenylene)vinylenyl]-l,l’-biphenyl);二萘嵌苯;取代 的二萘嵌苯;四·叔丁基二萘嵌苯(“TBPe”);雙(3,5-二氟-2-(2-吡啶基)苯基-(2-羧基吡啶基)銥III(“F(Ir)Pic”); 一種 芘;一種取代的芘;一種苯乙烯胺;一種氟化亞苯基; oxidazole; 1,8-萘二甲醯亞胺;一種聚唾啉;以及低逸出 功的金屬氧化物諸如氧化鈦和氧化鋅。 該裝置可進一步包括在該發射層和該電子傳輸層之間 的一電洞阻擋層。當該發射層係一電洞傳導層時,這個實 施方式係較佳的。該電洞阻擋層的一實例係2,9 -二甲基-4,7-二苯基- l,l〇-菲咯啉(也稱作浴銅靈(BCP))。 該第二傳導層起到一陰極的作用並且總的來說是一種 金屬的陰極,諸如除其他之外,Al、Ag、Ba、Ca以及它 們的組合。 在本發明的多個實施方式中,該發光裝置進一步包括 -46- 201041999 戒夠發出波長在250 nm至500 nm之間、較佳的是在 nm至450 nm之間的光的一光源。例如,根據本發明的多 個實施方式的一種發光裝置可以是一螢光燈,其中,氣體 塡充的管用一種螢光粉塗覆,該螢光粉包括一種根據本發 明的第一方面的發光材料。根據本發明的多個實施方式的 發光裝置的另一實例包括現有技術的一種有機的或無機的 藍色或近紫外的LED,包括根據本發明的第一方面的發射 0 材料的一個層。在一有機led(oled)的情況下,根據本發 明的第一方面的發光材料可以例如形成一個多層(例如, —個兩層)〇LED結構的頂層。在一無機LED的情況下, 根據本發明的第一方面的發光材料可以塗覆在鏡片上和/ 或包圍該LED的透明管殼上(較佳的是其內側)。爲此目的 ,可以使用例如從Le Group Fox,Inc.可商購的一種在360 nm處發射的5 mm紫外的LED。 Q 【實施方式】 實例 用於製備具有通式广]y的錯鹽的總體程序 將(a)—種具有通式+ 的鹽(其中Ml如以上給出 的所定義並且A係一種不發射的相對陰離子(例如Cl_、 Br·、PF6—、BF4·以及F·並且較佳的是Cl·)並且mx = pw), 以及 (b)—種具有通式[M2n — ]y[Cq + ]z的鹽(其中M2如以上給出的 所定義並且C係一種不發射的相對陽離子(例如Na+ ' K + -47- 201041999 、Li +以及NR4 +且較佳的是Κ + )並且ny = qz) 分別溶解在一合適的溶劑例如像甲醇中,並隨後將兩個溶 液結合。以一合適的量値(五倍於該溶劑(例如甲醇)的體積 量的量値通常是合適的量値)加入該錯鹽的一非溶劑(例如 水)並且除去(例如,在減壓下蒸發)該溶劑(例如甲醇)。將 沉澱物分離(例如過濾)並且純化(例如,在一 Sephadex柱 上使用一適當的洗脫液(例如甲醇))。當必要時,可以藉由例 如用一非溶劑(例如己烷)將所希望的錯合物+ 的 一溶液在一合適的溶劑(例如二氯甲烷)中進行緩慢沉澱、 或藉由對來自一所述適當溶劑中所希望的錯合物 + 的一溶液的適當溶劑(例如,甲醇)進行緩慢 蒸發而獲得進一步的純化。 EB 1 23的合成2 In any of the embodiments of the first aspect of the invention, an adhesion promoter may be included in the composition of the luminescent material. Such adhesion promoters are well known to those skilled in the art. This is particularly advantageous when the luminescent material is used to coat a substrate such as an inorganic LED envelope or a glass tube of a fluorescent lamp. In a second aspect, the invention relates to a process for the preparation of a luminescent material according to the first aspect of the invention and in particular a fault salt. In an embodiment of the second aspect, the present invention is directed to a method for producing a fault salt disclosed in any one of claims 1 to 11 characterized in that at least one of Salts of the formula [M,m + ]XA- -42- 201041999 and at least one salt of the formula [M2„-]yC+ may optionally be in the range of from 5 to 5 in the presence of at least one solvent. The reaction is carried out at a temperature between r (preferably from 15 〇c to 30 °c) to obtain a metal complex having the formula +, wherein the lanthanide is in the first to fourth aspects of the patent application. Any one defined, and A_ represents an anion selected from the group consisting of Cl, Br-, PF6., BF4., and F., wherein M2 is as defined above and C is selected from the group consisting of - Cationics: Na+, 0 K+, Li + and NR/where each R independently represents η or an alkyl group, and the metal complex can be optionally purified and/or isolated. Preferably, the C-kappa +, and/or the solvent is a solvent selected from the group consisting of polar aprotic solvents: methanol, ethanol, water, and mixtures thereof. The synthesis of a compound of the formula [Μ^+ΚΑ· and having the general formula [M2n-]yC + (among other things) is in K. Nazeeruddin et al., Am. Chem. Soc. 2003, 1 25, A detailed description is made in 8790 and Μ. K. Nazeeruddin et al., Inorg_Chem. 2007, 46, 5989. The corresponding portion of the disclosure of the Q content is hereby incorporated by reference. In a third aspect, the invention relates to An emissive layer illuminating device comprising or consisting of a luminescent material according to the first aspect of the invention. More preferably, the emissive layer is excited by a wavelength between 300 nm and 500 nm, Or when a voltage is applied across the emissive layer, light having a CIE 1931 coordinate U, y) in the range of (0.200, 0.200) to (0.550, 0.500) can be emitted. In various embodiments, the illumination The device is an organic light-emitting device - 43- 201041999. An organic light-emitting device generally comprises: • a substrate (preferably a transparent substrate), a first conductive layer (preferably a transparent conductive layer), • optionally, one or more holes are transmitted and/or Hole injection and/or electron blocking layer, • one or more emissive layers, • optionally, one or more electron transport and/or electron injection 'and/or hole blocking layers, and a second conductive layer. The substrate may be formed from one material or from more than one material. The substrate may be organic or inorganic, planar or non-planar. Examples of suitable inorganic substrates are glass and quartz. Examples of suitable organic substrates are transparent polymers such as, but not limited to, poly(methyl methacrylate) (PMMA) and polycarbonate. The substrate can be rigid or flexible. The first conductive layer functions as an anode. A typical example is tin oxide indium (ITO). Other examples are tin oxide doped with, for example, Sn or F. Useful materials for the hole injection layer (or hole transport layer or electron blocking layer) are well known to those skilled in the art and include, for example, polyaniline ("PANI"), poly (3,4- Ethylene dioxythiophene) ("PEDOT"), polypyrrole, various triarylamines and carbazoles, such as 4,4'-bis[N-(naphthyl)-N-phenyl-amino]biphenyl (α -NPD), hydrazine, hydrazine, -bis(3-methylphenyl)-indole, Ν'-diphenyl-[1,1,-biphenyl]-4,4,diamine (TPD), 4 ,4,-bis[Ν-(2-naphthyl)-fluorenyl-phenyl-amino]biphenyl (β-NPD), 4,4,,4"-tris(3-methylphenylanilinyl) Triphenylamine (MTDATA), 4,4'-oxime, Ν'-dicarbazole-biphenyl (CBP), Ν, Ν ', Ν "- -44- 201041999 1,3,5-tricarbazole benzene ( tCP) and 4,4',4"-tris(N-carbazolyl)-triphenylamine (TCTA). Alternatively, P-doping can be used to incorporate an electron acceptor such as tetrathiafulvalene tetracyanate Base dimethane salt ("tintin?-代\(5,,), 2,3,5,6-tetrafluoro-7,7,8,8-tetracyanodimethylphenylhydrazine (F4-TCNQ) And high-efficiency metal oxides, such as 'among other things, Molybdenum oxide, vanadium oxide, and tungsten oxide. The apparatus may further comprise an electron blocking layer between the emissive layer and the hole transport layer. This embodiment is preferred when the emissive layer is an electron conducting layer. In various embodiments of the invention, the one or more emissive layers are preferably a single emissive layer 'comprising or consisting of a luminescent material as defined in the co-brand of the present invention. Useful materials for the electron injecting layer (or electron transport layer or hole blocking layer) are well known to those skilled in the art and include, among other things, a metal chelating oxinoid compound (e.g. , Alq3 or Ming (III) bis(2-methyl-8-quinolinato) 4-phenylphenolate (''BAlq,' )); a phenanthroline-based compound (for example, 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline ("DDPA") or 9,10-diphenylanthracene ("DPA")); an azole compound (for example, 2-tert-butylphenyl-5-biphenyl-1,3,4-oxo) Azole ("?80") or 3-(4-biphenyl)-4-phenyl-5-(4-tert-butylphenyl)-1,2,4-triazole ("ΤΑΖ")); a diphenylanthracene derivative; a dinaphthyl anthracene derivative, 4,4-bis(2,2-diphenyl-vinyl-1-yl)-biphenyl ("DPVBI"); 9,10-two -β-naphthyl anthracene; 9,1〇-di-(naphthyl)anthracene; 9,10-di-(2-naphthyl)anthracene-45- 201041999 ("ADN"); 4,4f-double (咔Azul-9-)biphenyl ("CBP"): 9,10-bis-[4-(2,2-diphenylvinyl)-phenyl]-oxime ("80?¥?八"); ; 1 aryl benzimidazole (such as "ΤΡΒΙ"); I, 4 · bis [2-(9-ethyl-3-carbazole)vinyl]benzene (l,4-bis[2-(9-ethyl) -3-carbazoyl)vinylenyl]benzene) ; 4,4'-bis[2-(9-ethyl-3-oxazolyl)vinyl]-1,1'-biphenyl (4,4'-1)丨8[2-(9-6 seven 11; ^1-3-. &1^37〇丫1)乂111)^611丫1]-1,1'-1)011611丫1);9,1〇-double [2,2-(9,9-mercapto)) (9,10-bis[2,2-(9,9-fluorenylene) vinylenyl]anthracene) ; 1,4-bis[2,2-(9,9-fluorenyl)ethyl]benzene (l,4-bis[2,2-(9,9-fluorenylene)vinylenyl]benzene) ; 4,4'-bis[2,2-(9,9-fluorenyl)vinyl]-1,1' -biphenyl (4,4'-1>丨3[2,2-(9,9-fluorenylene)vinylenyl]-l,l'-biphenyl);perylene; substituted perylene; Tert-butyl perylene ("TBPe"); bis(3,5-difluoro-2-(2-pyridyl)phenyl-(2-carboxypyridinyl)phosphonium III ("F(Ir)Pic" a hydrazine; a substituted hydrazine; a styrylamine; a fluorinated phenylene; an oxidazole; 1,8-naphthyldimethylimine; a polysalrin; and a metal oxide having a low work function such as Titanium oxide and zinc oxide. The apparatus may further comprise a hole blocking layer between the emissive layer and the electron transporting layer. This embodiment is preferred when the emissive layer is a hole conducting layer. An example of a hole blocking layer is 2,9-dimethyl-4,7-diphenyl- l,l〇- Porphyrin (also known as bath copper spirit (BCP)). The second conductive layer functions as a cathode and is generally a metal cathode such as, among others, Al, Ag, Ba, Ca, and Combinations of the same. In various embodiments of the invention, the illumination device further comprises -46-201041999 to emit light having a wavelength between 250 nm and 500 nm, preferably between nm and 450 nm. A light source, for example, a light-emitting device according to various embodiments of the present invention may be a fluorescent lamp, wherein the gas-filled tube is coated with a phosphor powder, the phosphor powder comprising a first according to the present invention A luminescent material of the aspect. Another example of a light-emitting device according to various embodiments of the present invention includes an organic or inorganic blue or near-ultraviolet LED of the prior art, comprising an emission 0 material according to the first aspect of the present invention. A layer of luminescent material according to the first aspect of the invention may, for example, form a top layer of a multilayer (eg, two layers) 〇LED structure. In the case of an inorganic LED The luminescent material according to the first aspect of the invention may be applied to the lens and/or to the transparent envelope surrounding the LED (preferably its inner side). For this purpose, for example, from Le Group Fox, Inc. A commercially available 5 mm UV LED that emits at 360 nm. Q [Embodiment] An overall procedure for preparing a fault salt having a broad formula y will be (a) a salt having the formula + (wherein M1 is as defined above and A is not emitted) Relative anions (eg Cl_, Br·, PF6—, BF4· and F· and preferably Cl·) and mx = pw), and (b) have the general formula [M2n — ]y[Cq + ]z a salt (wherein M2 is as defined above and C is a relative cation that does not emit (eg Na+ 'K + -47- 201041999, Li + and NR4 + and preferably Κ + ) and ny = qz) Dissolve separately in a suitable solvent such as, for example, methanol, and then combine the two solutions. Adding a suitable amount of hydrazine (amount of five times the volume of the solvent (eg, methanol) is usually a suitable amount) adding a non-solvent (eg, water) of the wrong salt and removing (eg, under reduced pressure) Evaporate) the solvent (eg methanol). The precipitate is separated (e. g., filtered) and purified (e.g., using a suitable eluent (e.g., methanol) on a Sephadex column). When necessary, a solution of the desired complex + can be slowly precipitated in a suitable solvent (for example, dichloromethane) by, for example, using a non-solvent such as hexane, or by a pair. A suitable solvent (e.g., methanol) of a solution of the desired complex + in the appropriate solvent is slowly evaporated to provide further purification. Synthesis of EB 1 23

E B 1 2 3係藉由將甲醇和二氯甲烷的一溶劑混合物中的相應 氯氧基橋銥二聚錯合物在KCN的存在下進行回流而獲得 。將該等溶劑進行蒸發並且將粗製的殘留物溶解在甲醇中 。加入水,將沉澱物過濾、用水洗滌並且乾燥,得到錯合 物 E B 1 2 3。 -48- 201041999 EBPPbp的合成E B 1 2 3 is obtained by refluxing the corresponding chlorooxy bridged dimeric complex in a solvent mixture of methanol and dichloromethane in the presence of KCN. The solvents were evaporated and the crude residue was dissolved in methanol. Water was added, the precipitate was filtered, washed with water and dried to give a mixture of E B 1 2 3 . -48- 201041999 Synthesis of EBPPbp

❹ 該化合物係按照 Μ· K. Nazeeruddin等人的Inorg. Chem. 2007, 46,5989進行合成的,有一點改變:在將二 氯甲烷中的相應的氯氧基橋銥二聚錯合物在聯吡啶的存在 下進行回流之後,將溶劑蒸乾。將該粗製的混合物溶解在 最小量的二氯甲烷中並用二乙醚進行沉澱。將該沉澱物過 濾、用二乙醚洗滌並乾燥,得到作爲氯化物鹽的錯合物 EBPPbp ° 〇 E B 1 2 4的合成❹ This compound was synthesized according to Μ·K. Nazeeruddin et al., Inorg. Chem. 2007, 46, 5989 with a slight change: the corresponding chlorooxy bridged dimeric complex in dichloromethane After refluxing in the presence of bipyridine, the solvent was evaporated to dryness. The crude mixture was dissolved in a minimum amount of dichloromethane and precipitated with diethyl ether. The precipitate was filtered, washed with diethyl ether and dried to give a compound as a chloride salt. EBPPbp ° 〇 E B 1 2 4

-49- 201041999 向在甲醇中以1 : 1的比例的EB 1 23和EBPPbp的一混 合物中加入水。蒸發掉甲醇,將沉澱物過濾、乾燥並在 Sephadex上純化。將如此獲得的固體溶解在最小量的二氯 甲烷中並加入二乙醚中。在過濾並乾燥之後,得到作爲淡 橙色固體的EB124。 *H NMR (CDC13, 400 MHz): 9.78 (2H, d); 9.17 (2H, d); 8.21 (4H, d); 7.98 (2H, d); 7.93 (2H, d); 7.77 (2H, t); 7.71 (2H, d); 7.66 (2H, t); 7.51 (2H, d), 7.37 (2H, t); 7.08 (2H, t), 7.02 (2H, t); 6.96 (4H, t); 6.31 (2H, d); 6.23 (2H, t); 5_75 (2H, d)。 E B 8 7的合成-49- 201041999 Water was added to a mixture of EB 1 23 and EBPPbp in a ratio of 1:1 in methanol. The methanol was evaporated, the precipitate was filtered, dried and purified on EtOAc. The solid thus obtained was dissolved in a minimum amount of methylene chloride and added to diethyl ether. After filtration and drying, EB124 was obtained as a pale orange solid. *H NMR (CDC13, 400 MHz): 9.78 (2H, d); 9.17 (2H, d); 8.21 (4H, d); 7.98 (2H, d); 7.93 (2H, d); 7.77 (2H, t 7.71 (2H, d); 7.66 (2H, t); 7.51 (2H, d), 7.37 (2H, t); 7.08 (2H, t), 7.02 (2H, t); 6.96 (4H, t) ; 6.31 (2H, d); 6.23 (2H, t); 5_75 (2H, d). Synthesis of E B 8 7

2+ 12+ 1

Ir(2-苯基吡啶)2CN2K按照以上描述的用於EB123合 成的相同程序進行合成。Ru(4,7 -二苯基菲咯啉)3C12如 -50- 201041999 A ngew. Chem . In t. Ed. 2009, 4 8, 9277 中戶斤報告的進行合 成。 使用Ir(2-苯基吡啶)2CN2K和Ru(4,7-聯苯基菲咯啉 )3 Cl2施用以上描述的用於 EB 124的相同的程序來合成 EB 8 7,它作爲紅橙色固體獲得。 'H (400 MHz, CDC13): d 9.56 (4H, d); 8.72 (6H, d); 8.10 (6H, s); 7.65-7.4 1 (44H, m); 7.37 (4H, t); 6.72 (4H, t); 6.62 (4H, t); 6.34 (4H,t) 6_18 (4H, d)。 EB265 a)鹼性玫瑰精B甲酯的合成Ir(2-phenylpyridine)2CN2K was synthesized according to the same procedure as described above for EB123 synthesis. Ru(4,7-diphenylphenanthroline) 3C12, for example, -50-201041999 A ngew. Chem. In t. Ed. 2009, 4 8, 9277 The synthesis of the Zhongjijin report. The same procedure described above for EB 124 was used to synthesize EB 8 7 using Ir(2-phenylpyridine) 2CN2K and Ru(4,7-biphenylphenanthroline) 3 Cl2 to obtain a red-orange solid. . 'H (400 MHz, CDC13): d 9.56 (4H, d); 8.72 (6H, d); 8.10 (6H, s); 7.65-7.4 1 (44H, m); 7.37 (4H, t); 6.72 ( 4H, t); 6.62 (4H, t); 6.34 (4H, t) 6_18 (4H, d). EB265 a) Synthesis of basic rose essence B methyl ester

將鹼性玫瑰精B (2 5 0 m g)溶解於甲醇中。向該溶液中 逐滴加入乙醯氯(3 mL)並將該混合物在氬的氣氛中在50°C 下加熱。在24小時之後,逐滴加入乙醯氯(3 mL)並將該 混合物進一步加熱另外的24小時。將溶液蒸乾並在用 CHaCh/EhO洗脫的—矽膠色譜柱上進行純化。 b)EB265的合成 -51 - 201041999Alkaline rose essence B (250 m g) was dissolved in methanol. To the solution, acetonitrile (3 mL) was added dropwise and the mixture was heated at 50 ° C under an argon atmosphere. After 24 hours, ethyl hydrazine chloride (3 mL) was added dropwise and the mixture was further heated for additional 24 hours. The solution was evaporated to dryness and purified on a silica gel column eluting with CH.sub. b) Synthesis of EB265 -51 - 201041999

用鹼性玫瑰精B甲酯和EB 1 23,施用以上描述的用於 EB 124的同樣的合成程序來合成EB 265,它係作爲一粉-紫 色的固體獲得的。 *H NMR (400 MHz, dmso-i/6): d 9.47 (2H, d); 8.20 (3H, m); 8.02 (2H, t); 7.87 (1H, t); 7.78 (1H, t); 7.42 (3H, m); 7.05 -6.93 (6H, m); 6.54 (2H, t); 5.48 (2H, dd); 3.76 (1 1 H , m); 1 _ 2 4 (1 2 H,s)。 EB266的合成 a)EB230的合成EB 265 was synthesized using the same synthetic procedure described above for EB 124 using basic rose essence B methyl ester and EB 1 23, which was obtained as a powder-purple solid. *H NMR (400 MHz, dmso-i/6): d 9.47 (2H, d); 8.20 (3H, m); 8.02 (2H, t); 7.87 (1H, t); 7.78 (1H, t); 7.42 (3H, m); 7.05 -6.93 (6H, m); 6.54 (2H, t); 5.48 (2H, dd); 3.76 (1 1 H , m); 1 _ 2 4 (1 2 H, s) . Synthesis of EB266 a) Synthesis of EB230

施用如上描述的用於EBPPbp(按照Μ· K. Nazeeruddin 等人的Inorg. Chem. 200 7, 46, 5989有一點改變)的相同的 程序來獲得作爲一淡綠色-黃色的輕的固體的E B 2 3 0。The same procedure as described above for EBPPbp (slightly changed according to org·K. Nazeeruddin et al., Inorg. Chem. 200 7, 46, 5989) was applied to obtain EB 2 as a pale green-yellow light solid. 3 0.

^ NMR (400 MHz, CDC13): d 9.41 (2H, d); 8.36 (2H 201041999 d); 7.94 (2H, d); 7.45 (2H, dd); 6.95 (2H, d); 6.66 (2H, dt); 6.64 (2H, t); 5.71 (2H, dd); 1.56 (18H, s)。 b)N947的合成^ NMR (400 MHz, CDC13): d 9.41 (2H, d); 8.36 (2H 201041999 d); 7.94 (2H, d); 7.45 (2H, dd); 6.95 (2H, d); 6.66 (2H, dt ); 6.64 (2H, t); 5.71 (2H, dd); 1.56 (18H, s). b) Synthesis of N947

施用如上描述的用於Ir(PPyh(NCS)2TBA的相同的程 序、並且用[Ir(2-苯基-4-COOMe-吡啶)2C1]2(它係如 2009, 2, 3〇5中所描述的進行合成的)起始的 來獲得作爲N和S配位的種類的混合物的N94 7。 c)EB266的合成The same procedure as described above for Ir (PPyh (NCS) 2TBA was applied, and [Ir(2-phenyl-4-COOMe-pyridine) 2C1] 2 was used (this is as in 2009, 2, 3〇5) The synthesis described is initiated to obtain N94 7 as a mixture of species of N and S coordination. c) Synthesis of EB266

〇 施用如上所描述的用於EB 1 24的相同程序以及因爲 TBA相對陽離子的另外預備步驟:將EB23 0和N947溶解 於一甲醇/CH2C12混合物中並在加入水以及蒸發甲醇之前 -53- 201041999 將二氯甲烷蒸發掉。得到作爲一橙色固體的E B 2 6 6。 *H NMR (400 MHz, CDC13): d 10.09 (2H, d); 9.57 (2H, d); 9.29 (2H, d); 9.21 (2H, d); 8.92 (6H, bs); 8.44 (6H, d); 8.32 (6H, d); 7.93 (6H, d); 7.79 (2H, d); 7.75- 7.55 (8H, m); 7.46 (8H, m); 7.08 (6H, bs); 6.88 (4H, m); 6.8 2 -6.5 5 ( 1 8H, m); 6.12 (4H, ra); 6.02 (2H, d); 5.71 (6H, d); 4.14 (6H, s); 4.13 (3H, s); 4.12 (3H, s); 4.06 (6H, s); 1 .5 3 (54H, s)。 EB267的合成 a)EB206(H)2 的合成〇 apply the same procedure as described above for EB 1 24 and an additional preparatory step for TBA relative cations: dissolve EB23 0 and N947 in a methanol/CH 2 C 12 mixture and before adding water and evaporating methanol -53-201041999 The dichloromethane was evaporated. E B 2 6 6 was obtained as an orange solid. *H NMR (400 MHz, CDC13): d 10.09 (2H, d); 9.57 (2H, d); 9.29 (2H, d); 9.21 (2H, d); 8.92 (6H, bs); 8.44 (6H, d); 8.32 (6H, d); 7.93 (6H, d); 7.79 (2H, d); 7.75- 7.55 (8H, m); 7.46 (8H, m); 7.08 (6H, bs); 6.88 (4H , m); 6.8 2 -6.5 5 ( 1 8H, m); 6.12 (4H, ra); 6.02 (2H, d); 5.71 (6H, d); 4.14 (6H, s); 4.13 (3H, s) ; 4.12 (3H, s); 4.06 (6H, s); 1. 5 3 (54H, s). Synthesis of EB267 a) Synthesis of EB206(H)2

EB206(H)2 女口 以前幸艮告的(C/ze/n5wsC/iew, 2009, 2, 3 05)進行合成:將相應的甲醚EB2 06在甲醇中與20個當 量的四丁基氫氧化銨在室溫下攪拌過夜。然後加入去離子 水並蒸發掉甲醇。藉由加入稀的H C1水溶液而使酸取代的 錯合物沉澱,過濾、用去離子水洗滌並且在親脂性 Sephadex®柱上以甲醇爲洗脫液進行純化。 'H NMR (400 MHz; DMF-i7): δ 9.18 (2Η, s); 8.81 (2H, d); 8.78 (2H, d); 8.61 (2H, d); 8.18 (2H, d); 7.78 -54- 201041999 (2H, t); 7.62 (2H, t); 7.52 (2H, dd); 7.28 (2H, t); 6.65 (2H,t); 6.26 (2H, dd); 5.27 (1H,s); 1.72 (6H, s)。 b)EB267的合成EB206(H)2 Women's mouth was previously fortunately reported (C/ze/n5wsC/iew, 2009, 2, 3 05) for synthesis: the corresponding methyl ether EB2 06 in methanol with 20 equivalents of tetrabutyl hydrogen The ammonium oxide was stirred at room temperature overnight. Then deionized water was added and the methanol was evaporated. The acid-substituted complex precipitated by addition of a dilute aqueous solution of HCI, filtered, washed with deionized water and purified on a lipophilic Sephadex® column eluting with methanol. 'H NMR (400 MHz; DMF-i7): δ 9.18 (2Η, s); 8.81 (2H, d); 8.78 (2H, d); 8.61 (2H, d); 8.18 (2H, d); 7.78 - 54- 201041999 (2H, t); 7.62 (2H, t); 7.52 (2H, dd); 7.28 (2H, t); 6.65 (2H, t); 6.26 (2H, dd); 5.27 (1H, s) ; 1.72 (6H, s). b) Synthesis of EB267

將EB206(H)2溶解於0.1 M的NaOH水溶液中並加入 一粉末的E B 2 3 0。向該懸浮液中加入甲醇直到得到一溶液 。然後加入水直到發生沉澱。過濾之後用水洗滌,產生一 淡紅色固體。將該固體在一親脂性Sephadex®柱上以甲醇 爲洗脫液進行純化。蒸發第一部分,將其溶解在最少的甲 醇中並倒入醚中。將該沉澱物過濾並用醚洗滌。 Q NMR (400 MHz; CD30D): δ 9.1 1 (2H,s); 8.80 (2H, d); 8.73 (4Η, d); 8.63 (2H, d); 8.53 (4H, d); 8.41 (2H, d); 8.04 (4H, d); 7.94 (2H, d); 7.64 (4H, dd); 7.50 (2H, t); 7.29 (2H, dd); 7.16 (2H. dt); 7.10 (4H, d); 6.82 (4H, ddd); 6.67 (4H, t); 6.54 (2H, t); 6.29 (2H, d); 5.72 (4H, dd); 5.19 (1 H, s); 1.72 (6H, s); 1.47 (3 6H, s)。 在 DMSO 中,EB123(虛線)、EBPPbp(正方形)、 EB124(圓圈)的以及EB123的光譜與EBPPbp的光譜的疊 加(實線)的吸收光譜如圖1所示。EB 124的吸收光譜非常 -55- 201041999 接近於E B 1 2 3和E B P P b p的吸收光譜的總和。這表明在處 於基態的、並且是1 : 1的化學計量比的兩個部分之間沒有 或只有小的相互作用。 圖2示出了在未脫氣的DMSO中EB123在350 nm的 激發下的發射光譜。它發出藍光,其最大發射在484 nm( 實線)處。還顯示出在454 nm處跟隨的吸收(十字)和激發 光譜(圓圈)。在半高度處的線的寬度(FWMH)等於8 1 nm ’ X色度座標(CIE 1931)係等於 0.169,y色度座標(CIE 1 9 3 1 )係等於 0 · 2 9 1。 圖3示出了在未脫氣的 DMSO溶液中,EBPPbp在 350 nm的激發下的發射光譜。它發出橙色,其最大發射在 607 nm(實線)處。還顯示出在607 nm處跟隨的吸收(十字) 和激發光譜(圓圈)。FWMH等於119 nm,X色度座標(CIE 1931)係等於0.555,y色度座標(CIE 1931)係等於0.437。 圖4示出了在未脫氣的DMSO溶液中EB 124的發射 光譜。該激發在350 nm下進行。最大吸收波長係483 nm 。FWMH 係 224 nm,X 色度座標(CIE 1931)係等於 0.374, y色度座標(CIE 1931)係等於0.370。 包括EB124和一 PVP基質的發射材料 將EB124以按乾重計0_25%或按乾重計4.4%的量値 溶解於一 PVP溶液中。該溶液已經塗覆在一透明的底物上 。已經觀察到具有以下CIE 1931座標的白光: 對於 4.4 w t % 的膜係(0.4 0,〇 . 4 9 ) -56- 201041999 對於 0 · 2 5 w t % 的膜係(ο · 3 8,0.4 4) NMR光譜學 使用一台Bruker AV 400光譜儀記錄了 NMR光譜。 紫外-可見(UV-VIS)光譜學 紫外-可見光譜在一台HP 8452A上在DMSO溶液中以 從ΙΟ — 7 mM至10·4 mM的濃度進行測量。 光致發光光譜學 光致發光光譜在一台Spex Fluorolog 112分光螢光計 上使用9〇°C的光學幾何進行測量。光致發光光譜測量(以 從10 — 7 mM至1(T4 mM的濃度)在室溫下在DMSO溶液中 進行。 色度 CIE座標的測定如下:對CIE色度座標的計算係藉由 將每個波長處的光譜能量與這三個顏色匹配函數的每個的 加權因數相乘而得到。計算該等分量的總和得到三色刺激 値X、Y和Z,由此得出如下色度座標: x = X/(X + Y + Z)以及 y = Y/(X + Y + Z)。 【圖式簡單說明】 圖1係在二甲基亞楓(DMSO)中一藍色發射的陰離子 -57- 201041999 金屬錯合物(EB 123 )(虛線)、一紅色發射的陽離子金屬錯合 物(EBPPbp)(正方形)、一種根據本發明的一實施方式的錯 鹽(EB124)(圓圏)、以及EB123的吸收光譜與EBPPbp吸收 光譜的(實線)的數學求和的吸收光譜。 圖 2係一藍色發射陰離子金屬錯合物(EB 12 3)在 D M S Ο中的吸收(+ )、激發(〇 )和發射(實線)光譜。 圖3係一紅色發射陰離子金屬錯合物(EBPPbp)在 DMSO中的吸收(+ )、激發(〇)和發射(實線)光譜。 圖4係一種根據本發明的一實施方式的錯鹽(EB124) 在DMSO中的吸收(+ )、激發(0)和發射(實線)光譜。 圖5係一種雙錯合的鹽(EB87)在脫氣的DMSO中在 400 nm激發下的發射光譜。 圖6係一種單錯合的鹽(EB265 )在脫氣的DMS◦中在 400 nm處激發下的發射光譜。 圖7係一種雙錯合的鹽(EB266)在脫氣的DMSO中在 400 nm激發下的發射光譜。 圖8係一種雙錯合的鹽(EB267)在脫氣的DMSO中在 4〇〇 nm激發下的發射光譜。 -58-EB206(H)2 was dissolved in 0.1 M aqueous NaOH and a powder of E B 2 3 0 was added. Methanol was added to the suspension until a solution was obtained. Water is then added until precipitation occurs. After filtration, it was washed with water to give a pale red solid. The solid was purified on a lipophilic Sephadex® column eluting with methanol. The first portion was evaporated, dissolved in a minimum of methanol and poured into ether. The precipitate was filtered and washed with ether. Q NMR (400 MHz; CD30D): δ 9.1 1 (2H, s); 8.80 (2H, d); 8.73 (4Η, d); 8.63 (2H, d); 8.53 (4H, d); 8.41 (2H, d); 8.04 (4H, d); 7.94 (2H, d); 7.64 (4H, dd); 7.50 (2H, t); 7.29 (2H, dd); 7.16 (2H.dt); 7.10 (4H, d 6.82 (4H, ddd); 6.67 (4H, t); 6.54 (2H, t); 6.29 (2H, d); 5.72 (4H, dd); 5.19 (1 H, s); 1.72 (6H, s ); 1.47 (3 6H, s). In DMSO, the absorption spectra of EB123 (dashed line), EBPPbp (square), EB124 (circle), and the overlap of the spectrum of EB123 and the spectrum of EBPPbp (solid line) are shown in Fig. 1. The absorption spectrum of EB 124 is very close to -55- 201041999. It is close to the sum of the absorption spectra of E B 1 2 3 and E B P P b p . This indicates that there is no or only a small interaction between the two parts in the ground state and having a stoichiometric ratio of 1:1. Figure 2 shows the emission spectra of EB123 at 350 nm in undegassed DMSO. It emits blue light with a maximum emission at 484 nm (solid line). It also shows the absorption (cross) and excitation spectrum (circles) following at 454 nm. The width of the line at half height (FWMH) is equal to 8 1 nm 'X chromaticity coordinates (CIE 1931) is equal to 0.169, and the y chromaticity coordinate (CIE 1 9 3 1 ) is equal to 0 · 2 9 1 . Figure 3 shows the emission spectra of EBPPbp at 350 nm excitation in an undegassed DMSO solution. It emits orange with a maximum emission at 607 nm (solid line). It also shows the absorption (cross) and excitation spectrum (circles) following at 607 nm. FWMH is equal to 119 nm, X chromaticity coordinates (CIE 1931) is equal to 0.555, and y chromaticity coordinates (CIE 1931) is equal to 0.437. Figure 4 shows the emission spectrum of EB 124 in an undegassed DMSO solution. The excitation was carried out at 350 nm. The maximum absorption wavelength is 483 nm. The FWMH system is 224 nm, the X chromaticity coordinate (CIE 1931) is equal to 0.374, and the y chromaticity coordinate (CIE 1931) is equal to 0.370. Emissive material comprising EB124 and a PVP matrix EB124 was dissolved in a PVP solution in an amount of 0-25% by dry weight or 4.4% by dry weight. The solution has been coated on a transparent substrate. White light with the following CIE 1931 coordinates has been observed: for 4.4 wt% of the membrane system (0.4 0, 〇. 4 9 ) -56- 201041999 for 0 · 2 5 wt % of the membrane system (ο · 3 8, 0.4 4) NMR spectroscopy NMR spectra were recorded using a Bruker AV 400 spectrometer. UV-VIS spectroscopy Ultraviolet-visible spectroscopy was measured on a HP 8452A in DMSO solution at a concentration from ΙΟ-7 mM to 10.4 mM. Photoluminescence Spectroscopy Photoluminescence spectra were measured on a Spex Fluorolog 112 spectrofluorometer using an optical geometry of 9 °C. Photoluminescence spectroscopy (measured from 10-7 mM to 1 (T4 mM concentration) in DMSO solution at room temperature. The chromaticity CIE coordinates were determined as follows: CIE chromaticity coordinates were calculated by The spectral energy at each wavelength is multiplied by the weighting factor of each of the three color matching functions. Calculating the sum of the equal components yields three color stimuli 値X, Y, and Z, thereby yielding the following chromaticity coordinates: x = X/(X + Y + Z) and y = Y/(X + Y + Z) [Simplified illustration] Figure 1 shows an anion emitted by blue in dimethyl sulfoxide (DMSO) - 57- 201041999 metal complex (EB 123 ) (dashed line), a red-emitting cationic metal complex (EBPPbp) (square), a wrong salt (EB124) according to an embodiment of the present invention, And the absorption spectrum of the EB123 absorption spectrum and the EBPPbp absorption spectrum (solid line). Figure 2 is the absorption (+) and excitation of a blue-emitting anion metal complex (EB 12 3) in DMS Ο (〇) and emission (solid line) spectra. Figure 3 is a red-emitting anionic metal complex (EBPPbp) at D Absorption (+), excitation (〇), and emission (solid line) spectra in MSO. Figure 4 is an absorption (+), excitation (0) of a fault salt (EB124) in DMSO according to an embodiment of the present invention. And emission (solid line) spectra. Figure 5 is an emission spectrum of a double-missing salt (EB87) in degassed DMSO at 400 nm. Figure 6 is a single-missing salt (EB265) in degassing. Emission spectrum at 400 nm excitation in DMS◦ Figure 7 is an emission spectrum of a double-missing salt (EB266) in degassed DMSO at 400 nm. Figure 8 is a double-missing salt. (EB267) Emission spectrum at 4 〇〇 nm excitation in degassed DMSO. -58-

Claims (1)

201041999 七、申請專利範圍: 1· 一種白光發射材料,包括具有通式的 一錯鹽,其中: • xm = yn, • 和[Μ2"-]係離子的發光部分,它們具有g補的發 射光譜,一個在可見光譜的藍色區域內發射,而另—個在 可見光譜的紅色區域內發射,並且 〇 其中Μ,和M2中的至少一個係一種金屬錯合物。 2 ·如申請專利範圍第1項所述之白光發射材料,其中 + h和%广;^中的一個其發射光譜在5 5 0 ηιη至740 nm範圍內具有一最大發射波長,並且另一個其發射光譜 在390 nm至55〇 nm範圍內具有一最大發射波長,並且該 錯鹽能夠發射出在從( 0.200,0.200)至(0.550,〇 5〇〇 )的範圍內具有CIE 1931座標(X,y)的光。 3 .如申請專利範圍第1項所述之白光發射材料,進— Q 步包括作爲一基質之具有至少3.0的介電常數的液體的、 凝膠的或固體的極性的、非離子的一介質或一聚合物。 4.如申請專利範圍第3項所述之白光發射材料,其中 該極性的、非離子之介質係一電洞和/或電子傳輸材料。 5 ·如申請專利範圍第3項所述之白光發射材料,其中 該極性的、非離子的介質包括一種離子的摻雜劑,如一種 離子液體。 6 ·如申請專利範圍第1項所述之白光發射材料,其中 係選自·· D(X)2(Y)2、D(X)2Z、FTL、G(U)2 以及 CuP2, -59- 201041999 和/或m2係e(w)2s,其中 D代表選自以下的一種金屬離子·· Ir、Ru、0s以及201041999 VII. Patent application scope: 1. A white light emitting material, including a wrong salt with a general formula, wherein: • xm = yn, • and [Μ2"-] are the luminescent parts of the ion, which have an emission spectrum of g complement One emits in the blue region of the visible spectrum, and the other emits in the red region of the visible spectrum, and in which Μ, and at least one of M2 is a metal complex. 2. The white light emitting material according to claim 1, wherein + h and % are broad; one of the emission spectra has a maximum emission wavelength in the range of 5 5 0 ηιη to 740 nm, and the other The emission spectrum has a maximum emission wavelength in the range of 390 nm to 55 〇 nm, and the wrong salt can emit CIE 1931 coordinates (X, in the range from (0.200, 0.200) to (0.550, 〇5 〇〇). y) light. 3. The white light emitting material according to claim 1, wherein the step Q comprises, as a substrate, a liquid, gel or solid polar, nonionic medium having a dielectric constant of at least 3.0 Or a polymer. 4. The white light emitting material of claim 3, wherein the polar, nonionic medium is a hole and/or an electron transporting material. 5. The white light emitting material of claim 3, wherein the polar, nonionic medium comprises an ion dopant such as an ionic liquid. 6. The white light emitting material according to claim 1, wherein the color is selected from the group consisting of D(X)2(Y)2, D(X)2Z, FTL, G(U)2, and CuP2, -59 - 201041999 and/or m2 is e(w)2s, where D represents a metal ion selected from the following: Ir, Ru, 0s and 由此具有通式I的多個化合物藉由—sp2混成的碳原 子以及一sp2混成的氮原子與D配位’並且具有通式la的 多個化合物藉由兩個sp2混成的氮原子與D配位; 其中R1表示選自以下的一個部分:F、cl、-〇-烷基 、-C( = 〇)-〇-烷基、-C( = 〇)-CF3、-CF3、-CN、烷基以及 Η 或者 R1 和 R2 — 起代表- CH = CH-CH = CH-; R2表示選自以下的一個部分:-〇-烷基、F、Cl、Br 、-C卜〇)-〇-烷基、-C( = 0)-CF3、-CF3、-CN、烷基以及 Η 或者 R2 和 R3 —起代表-CH = CH-CH = CH-; R3表示選自以下的一個部分:-C(=0)-0-烷基、Η、-C(=0)-CF3 -CF3、-CN、烷基、-Ο-烷基、-N (烷基)2以及-N (烷基)3 -60- 201041999 或者 R3 和 R4 — 起代表-CH = CH-CH = CH-; R4表示選自以下的—個部分:-c(=〇)-〇-烷基、-c(=o)-cf3 、-Ο-烷基、烷基、H、F、Cl以及Br; 或者R4和R5 —起代表-CH = CH-; R5表示選自以下的一個部分:-C(=0)-0-烷基、-C(=0)-CF3 、-〇-烷基、烷基、H、F、Cl以及Br; 或者 R5 和 R6—起代表-CH=CH-CH=CH-或-CH2-CH=CH-CH2-; R6表示選自以下的一個部分:Η、烷基、-Ο-烷基、苯 基、-C( = 0)-0-烷基、-CF3、-C( = 0)-CF3、-CN ' ·Ν(烷基)2 以及-Ν(院基)3 ; 或者 R6 和 R7—起代表-CH=CH-CH=CH-或-CH2-CH=CH-CH2-; R7表示選自以下的一個部分:Η、F、Cl、Br、-CN 、-cf3、-〇-烷基、烷基、-c( = o)-o-烷基以及-c( = o)-cf3; 或者 R7 和 R8 —起代表-CH = CH-CH = CH-; 並且R8表示選自以下的一個部分:-CN、-CF3、-C(=0)-CF3 、-C( = 0)-0-烷基、烷基、烷基、h、F、Cl 以及 Br; 每個Y彼此獨立地代表選自以下的一個部分:F、Cl 、Br、CH3 -〇_ 烷基、〇H、-CN、-OCN 以及- SCN; 並且z代表一種具有通式II或Iia的化合物,Thus, a plurality of compounds of the formula I are coordinated to a D by a carbon atom of -sp2 and a nitrogen atom of a sp2 and a plurality of compounds of the formula la are a mixture of two sp2 nitrogen atoms and D Coordination; wherein R1 represents a moiety selected from the group consisting of F, cl, -〇-alkyl, -C(= 〇)-〇-alkyl, -C(= 〇)-CF3, -CF3, -CN, Alkyl and hydrazine or R1 and R2 together represent -CH = CH-CH = CH-; R2 represents a moiety selected from the group consisting of -〇-alkyl, F, Cl, Br, -C Di)-〇- Alkyl, -C(=0)-CF3, -CF3, -CN, alkyl and Η or R2 and R3 together represent -CH = CH-CH = CH-; R3 represents a moiety selected from the group consisting of -C (=0)-0-alkyl, hydrazine, -C(=0)-CF3-CF3, -CN, alkyl, -Ο-alkyl, -N(alkyl)2, and -N(alkyl)3 -60- 201041999 or R3 and R4 together represent -CH = CH-CH = CH-; R4 represents a part selected from the group consisting of -c(=〇)-〇-alkyl, -c(=o)- Cf3, -Ο-alkyl, alkyl, H, F, Cl, and Br; or R4 and R5 together represent -CH=CH-; R5 represents a moiety selected from the group consisting of -C(=0)-0- Alkyl, -C(=0)- CF3, -〇-alkyl, alkyl, H, F, Cl and Br; or R5 and R6 together represent -CH=CH-CH=CH- or -CH2-CH=CH-CH2-; One of the following: hydrazine, alkyl, -Ο-alkyl, phenyl, -C(=0)-0-alkyl, -CF3, -C(=0)-CF3, -CN' Base) 2 and - Ν (hospital) 3; or R6 and R7 - represent -CH=CH-CH=CH- or -CH2-CH=CH-CH2-; R7 represents a moiety selected from the group consisting of: F, Cl, Br, -CN, -cf3, -〇-alkyl, alkyl, -c( = o)-o-alkyl, and -c( = o)-cf3; or R7 and R8 together represent - CH = CH-CH = CH-; and R8 represents a moiety selected from the group consisting of -CN, -CF3, -C(=0)-CF3, -C(=0)-0-alkyl, alkyl, alkane Bases, h, F, Cl, and Br; each Y independently of one another represents a moiety selected from the group consisting of F, Cl, Br, CH3 -〇_alkyl, 〇H, -CN, -OCN, and -SCN; z represents a compound of the formula II or Iia, IIII Iia, -61 - 201041999 其中 R9、R1G、R11和R12彼此獨立地各自代表選自以下的 一個部分:-C( = 0)-0-烷基、烷基、苯基、Η、-N(烷基)2、 F、Cl、Br、-0 -烷基以及- CF3; 並且由此具有通式II和Ila的多個化合物藉由兩個 sp2混成的氮原子與D配位; F代表選自以下的一種金屬離子:Pt以及Au ; T代表一種具有通式III、Ilia或Illb的化合物Iia, -61 - 201041999 wherein R9, R1G, R11 and R12 each independently represent a moiety selected from the group consisting of -C(=0)-0-alkyl, alkyl, phenyl, fluorene, -N (alkane) a group of 2, F, Cl, Br,-0-alkyl and -CF3; and thus a plurality of compounds of the formula II and 11a are coordinated to D by a nitrogen atom mixed by two sp2; One of the following metal ions: Pt and Au; T represents a compound of the formula III, Ilia or 111b 由此具有通式Ilia和IIIb的多個化合物藉由一 sp2混 成的碳原子以及兩個sp2混成的氮原子與F配位,並且具 有通式III的多個化合物藉由三個SP2混成的氮原子與F 配位; 其中 R25、R26、R27、R28、R29、RW、Rn、和 R33彼此獨立地各自代表選自以下的一部分:F、Cl、-CN 、-C( = 0)-0 -院基、院基、院基、苯基、Η、-N(院基)2 以及-CF3 ; 並且L代表選自以下的一配位基:CO、·Ν(烷基)2、-NH2( -62 - 201041999 烷基)、F、Cl、Br、I、CN、〇CN、-Ο-烷基、-OH 以及 SCN ; G代表選自以下的一種金屬離子:Ir、Ru、Os以及 Rh ; 每個u彼此獨立地代表一種具有通式IV、IVa或IVb 的化合物,Thus, a plurality of compounds having the general formula Ilia and IIIb are coordinated to F by a sp2 mixed carbon atom and two sp2 mixed nitrogen atoms, and a plurality of compounds of the general formula III are mixed by three SP2 nitrogens. The atom is coordinated to F; wherein R25, R26, R27, R28, R29, RW, Rn, and R33 each independently represent a moiety selected from the group consisting of F, Cl, -CN, -C(=0)-0- a base, a base, a base, a phenyl, an anthracene, a -N (hospital) 2, and -CF3; and L represents a ligand selected from the group consisting of CO, hydrazine (alkyl) 2, -NH2 ( -62 - 201041999 alkyl), F, Cl, Br, I, CN, 〇CN, -Ο-alkyl, -OH and SCN; G represents a metal ion selected from the group consisting of Ir, Ru, Os and Rh; Each u independently of one another represents a compound of the formula IV, IVa or IVb, 由此具有通式IVa和IVb的多個化合物藉由一 sp2混成 的碳原子以及兩個sp2混成的氮原子與G配位,並且具有通 式IV的多個化合物藉由三個sp2混成的氮原子與〇配位; 其中 R34、R35、R36、R37、R38、R39、R4〇、R4i 和 R42 彼此獨立地各自代表-Ο-烷基、F、Cl、-CN、、c( = 0)_0-院 基、烷基、苯基、Η、-N(烷基)2以及-CF3 ; 其中每個P彼此獨立地代表一種具有通式IX或X的 化合物,Thus, a plurality of compounds of the formulae IVa and IVb are coordinated to G by a sp2 mixed carbon atom and two sp2 mixed nitrogen atoms, and a plurality of compounds of the formula IV are mixed by three sp2 nitrogens. The atom and the ruthenium coordinate; wherein R34, R35, R36, R37, R38, R39, R4〇, R4i and R42 each independently represent -Ο-alkyl, F, Cl, -CN,, c(=0)_0 a compound, an alkyl group, a phenyl group, a fluorene, -N(alkyl) 2 and -CF3; wherein each P independently of one another represents a compound of the formula IX or X, 63- IX 201041999 其中R63、R64、R65和R66彼此獨立地各自代表選自 以下的一個部分_· F、C 1、- C N、- C (= Ο ) - Ο -烷基、烷基 、-〇-烷基、苯基、Η' -N(烷基)2以及- CF3; 由此具有通式IX和X的多個化合物藉由兩個sp2混 成的氮原子與Cu配位; E代表選自以下的一種金屬離子:Ir、Ru、Os以及 Rh ; 每個W彼此獨立地代表一種具有通式I’或la'的化合 物,63- IX 201041999 wherein R63, R64, R65 and R66 each independently represent a moiety selected from the group below _· F, C 1 , — CN, — C (= Ο ) - Ο -alkyl, alkyl, -〇 - alkyl, phenyl, Η'-N(alkyl) 2 and -CF3; thus a plurality of compounds of the formula IX and X are coordinated to Cu by a nitrogen atom mixed by two sp2; One of the following metal ions: Ir, Ru, Os, and Rh; each W independently of each other represents a compound having the formula I' or la', 由此具有通式Γ的多個化合物藉由一 sp2混成的碳原 子以及一sp2混成的氮原子與E配位,並且具有通式la'的 多個化合物藉由兩個SP2混成的氮原子與E配位; 其中R13表示選自以下的一個部分:F、C1、-0-烷基 、-C( = 0)-0-烷基、-C( = 〇)-CF3、-CF3、-CN、烷基以及 Η , 或者 R13 和 R14 一起代表-CH = CH-CH = CH-; r14表示選自以下的一個部分:-C( = 〇)-〇-院基、-c( = 〇)-cf3 -64- 201041999 、-CF3、-CN、-0-烷基、F、Cl、Br 以及 Η ; 或者 R14 和 R15 起代表- CH = CH-CH = CH-’ r15表示選自以下的一個部分:-C(=0)-0-焼基、Η、-C(=0)-CF3 、-cf3、_CN、烷基、,〇-烷基、-m院基)2以及-n(院基)3 f 或者 R15 和 R16 — 起代表-CH = CH-CH = CH-; Rl6表示選自以下的一個部分:H、F、C卜-CN、-CF3、院 0 基、-ο-烷基以及Br ; 或者R16和R17 —起代表-CH = CH_; Rl7表示選自以下的—個部分:Η、_〇_烷基、烷基、-CN 、-CF3、F、C1 以及 Br; 或者 R17 和 R18 —起代表-CH=CH-CH=CH-或-CH2-CH=CH-CH2- » Rl 8表示選自以下的—個部分:Η、烷基、_〇·烷基、 苯基、-C( = 〇)_〇-烷基、-CF3、-C( = 0)-CF3、-CN、-Ν(烷基 Q )2以及-N(院基)3 ; 或者 R丨8 和 R19—起代表-CH=CH-CH=CH-或-CH2-CH=CH-CH2-; R19表示選自以下的一個部分:Η、-Ο-烷基、烷基、-CN 、-CF3、-C( = 〇)-CF3、F、C1 以及 Br; 或者 R19 和 R2G — 起代表-CH = CH-CH = CH-; 並且R2()表示選自以下的一個部分:-〇-烷基、烷基 、-CN、-CF3、-C( = 0)-CF3、F、C1 以及 Br; 並且S代表一種具有通式ΙΓ或Ila’的化合物, -65- 201041999Thus, a plurality of compounds having the general formula 配 are coordinated to E by a sp2 mixed carbon atom and a sp2 mixed nitrogen atom, and a plurality of compounds of the general formula la' are mixed with a nitrogen atom of two SP2 E-coordinate; wherein R13 represents a moiety selected from the group consisting of F, C1, -0-alkyl, -C(=0)-0-alkyl, -C(= 〇)-CF3, -CF3, -CN , alkyl and Η, or R13 and R14 together represent -CH = CH-CH = CH-; r14 represents a moiety selected from the group consisting of -C( = 〇)-〇-院, -c( = 〇)- Cf3 -64- 201041999, -CF3, -CN, -0-alkyl, F, Cl, Br and Η; or R14 and R15 represent - CH = CH-CH = CH-' r15 means a part selected from the following :-C(=0)-0-mercapto, fluorene, -C(=0)-CF3, -cf3, _CN, alkyl, 〇-alkyl, -m-院) 2 and -n ) 3 f or R15 and R16 — representing -CH = CH-CH = CH-; Rl6 represents a moiety selected from the group consisting of H, F, CBu-CN, -CF3, 院基基, -ο-alkyl And Br; or R16 and R17 together represent -CH=CH_; Rl7 represents a moiety selected from the group consisting of Η, 〇〇-alkyl, alkyl, -C N, -CF3, F, C1 and Br; or R17 and R18 together represent -CH=CH-CH=CH- or -CH2-CH=CH-CH2-» Rl 8 represents a part selected from the following: Η , alkyl, 〇 烷基 alkyl, phenyl, -C( = 〇)_〇-alkyl, -CF3, -C(=0)-CF3, -CN, -Ν(alkyl Q)2 and - N (hospital) 3; or R丨8 and R19 represent -CH=CH-CH=CH- or -CH2-CH=CH-CH2-; R19 represents a moiety selected from the group consisting of Η, -Ο- Alkyl, alkyl, -CN, -CF3, -C( = 〇)-CF3, F, C1 and Br; or R19 and R2G - represent -CH = CH-CH = CH-; and R2() means From one of the following: - fluorenyl-alkyl, alkyl, -CN, -CF3, -C(=0)-CF3, F, C1 and Br; and S represents a compound of the formula I or Ila', -65- 201041999 其中R21、R22、R23和R24彼此獨立地各自代表選自 以下的一個部分:H、-C( = 〇h〇-烷基、烷基、_〇_烷基、_CN 、苯基、Η、-N(烷基)2以及-CF3。 7.如申請專利範圍第1項所述之白光發射材料,其中 ,[Μ^Ί或[Μ2" — ]係一種發射性的有機的非金屬的離子, 它係選自:一種小分子、具有最多個重複單元的一種 低聚物、或被多個離子的基團取代的一種有機分子。 8 .如申請專利範圍第7項所述之白光發射材料,_中 或[M2n_]係選自:蒽、並四苯、酞菁類、咕噸、二 萘嵌苯、類、紅荧嫌、香丑素、驗性玫瑰精、紫菜域類 、咕琳類、嗤琳、唾卩「症嗣、一氨基亞甲基耻喃、花青類 、偶氮染料類、羰基染料類、聚烯類、聚甲炔類、嚷喃、 啦喃鏺、噻喃鏺、芴、低聚芴、茚並荀' 低聚節並场、 periflanthene、印並北、一(卩秦基)胺硼、一(嗪基)甲院、螢 光黃素類、喹諾酮、蒽醌類以及硼酸鹽(酯)類之有·機衍 生物,其中所述有機衍生物被選自s〇3_、s〇4'、C00-以 及-NR/的離子基團取代,其中每個R可以獨立地代表例 如Ci-Cr烷基或C5-C!。-芳基。 9.如申請專利範圍第8項所述之白光發射材料_,$中 -66 - 201041999 M i係對應於以下化學式V的一種二萘嵌苯衍生物或對應於 以下化學式VII的一種芴衍生物:Wherein R21, R22, R23 and R24 each independently represent a moiety selected from the group consisting of H, -C(= 〇h〇-alkyl, alkyl, 〇〇-alkyl, _CN, phenyl, fluorene, - N (alkyl) 2 and -CF3. 7. The white light-emitting material according to claim 1, wherein [Μ^Ί or [Μ2"-] is an emissive organic non-metal ion, It is selected from the group consisting of: a small molecule, an oligomer having the most repeating units, or an organic molecule substituted with a group of a plurality of ions. 8. The white light emitting material according to claim 7 of the patent application, _中或[M2n_] is selected from the group consisting of: 蒽, tetracene, phthalocyanine, xanthene, perylene, arsenic, red phoenix, fragrant scent, test rose essence, laver field, 咕琳, 嗤琳, 卩 卩 "symptoms, monoaminomethylene vaginal, cyanine, azo dyes, carbonyl dyes, polyenes, polymethines, sputum , 芴, 芴 芴, 茚 荀 荀 低 低 低 低 低 低 低 低 低 低 低 低 低 低 低 低 低 低 低 低 低 低 低 低 低 低 低 低 低 低 低 低 低 低 低 低 低 低 低 低 低 低 低An organic derivative of a quinolone, an anthraquinone, and a borate, wherein the organic derivative is substituted with an ionic group selected from the group consisting of s〇3_, s〇4', C00-, and -NR/, wherein Each R may independently represent, for example, a Ci-Cr alkyl group or a C5-C!-aryl group. 9. The white light emitting material as described in claim 8 of the patent application _, $中-66 - 201041999 M i corresponds A perylene derivative of the following chemical formula V or an anthracene derivative corresponding to the following chemical formula VII: ❹ 其中 R43和R44彼此獨立地各自表示選自以下的一個部分 :甲基、乙基、正丙基、異丙基、正丁基、叔丁基以及正 戊基; 並且R45、R46、R47和R48彼此獨立地各自表示選自 以下的一個部分:H、甲基、-◦·甲基、F、C1以及Br; 54 53 D R 55_NWherein R43 and R44 each independently represent a moiety selected from the group consisting of methyl, ethyl, n-propyl, isopropyl, n-butyl, t-butyl and n-pentyl; and R45, R46, R47 and R48 each independently represents a moiety selected from the group consisting of H, methyl, -◦·methyl, F, C1, and Br; 54 53 DR 55_N R R -67- VII 60 201041999 其中R 、R54、R55、R56、R57 和 R 彼此獨立地各自 可表示選自以下的一個部分:H、甲基、乙基、正两基、 異丙基、正丁基、叔丁基、正戊基; 並且R59和R6e彼此獨立地各自可表示選自以下的— 個部分:正戊基、新戊基、異戊基、正己基、正庚基、正 辛基或乙基己基。 10.如申請專利範圍第8項所述之白光發射材料,其 中M2係對應於化學式VI的一種二萘嵌苯衍生物或對應於 化學式V111的一種荀衍生物:RR -67- VII 60 201041999 wherein R, R54, R55, R56, R57 and R each independently represent a moiety selected from the group consisting of H, methyl, ethyl, n-diyl, isopropyl, n-butyl a group, a tert-butyl group, a n-pentyl group; and each of R59 and R6e independently of each other may represent a moiety selected from the group consisting of n-pentyl, neopentyl, isopentyl, n-hexyl, n-heptyl, n-octyl Or ethylhexyl. 10. The white light emitting material according to claim 8, wherein the M2 corresponds to a perylene derivative of the formula VI or an anthracene derivative corresponding to the formula V111: 其中1149、尺5()、1151和R52彼此獨立地各自表示選自 以下的一個部分:H、甲基、-〇_甲基、F' C1和Br; -68- 201041999 οWherein 1149, feet 5(), 1151 and R52 each independently represent a moiety selected from the group consisting of H, methyl, -〇-methyl, F' C1 and Br; -68- 201041999 VIII, 其中R61和R62彼此獨立地各自可表示選自以下的一 個部分:正戊基、新戊基、異戊基、正己基、正庚基、正 辛基或乙基己基。 1 1 .如申請專利範圍第1項所述之白光發射材料,其 中,對應於以下化學式中的任何一個: 2+VIII, wherein R61 and R62, each independently of each other, represent a moiety selected from the group consisting of n-pentyl, neopentyl, isopentyl, n-hexyl, n-heptyl, n-octyl or ethylhexyl. The white light emitting material according to the first aspect of the invention, which corresponds to any one of the following chemical formulas: 2+ -69 201041999-69 201041999 -70- 2. 201041999-70- 2. 201041999 /-,/-, b 1 2 · —種用於製備如申請專利範圍第1項中揭露的一 錯鹽之方法,其特徵在於:將至少—種具有通式[Μι:„ + ]χ Ο Α的鹽與至少—種具有通式[M2n-]y C +的鹽可隨意地在至 少一種溶劑的存在下、在範圍在丨〇乞至5 〇 ^之間,較佳 的是在15C至30C的溫度下進行反應,其中…係如申請 專利範圍第1至4項中的任—項所定義,並且Α·表示選自 以下的一種陰離子:cr、Br-、pf6.' BF4·以及F_,其中 M2係如申請專利範圍第1至4項中的任一項所定義並且^ 表不選自以下的一種陽離子Na+、K+、Li +以及NR4+,由 此每個R彼此獨立地表示Η或烷基,以此獲得一種具有通 Ο 式[Mim + ]x[M2n1y的金屬錯合物,該錯合物可隨意地被純 化和/或被分離。 1 3 . —種發光裝置,包括一發射層,包括如申請專利 範圍第1項的一種發光材料的該發射層在300 nm至500 nm之間的一波長下激發時、或在跨過該發射層施加一電 壓時,能夠發射出在從( 0.200,0.200)至( 0.550, 0.500)之範圍內具有CIE 1931座標(X, y)的光。 14.如申請專利範圍第13項所述之發光裝置,進一步 包括一光源,該光源能夠在250 nm至500 nm之間的波長 -71 - 201041999 上發射出光。 1 5 .如申請專利範圍第1 3項所述之發光裝置,其中, 該發射層係該裝置之唯一的發光層。 -72-b 1 2 · A method for preparing a fault salt as disclosed in claim 1 of the patent application, characterized in that at least one salt having the formula [Μι:„ + ]χ Ο 与 and at least The salt having the formula [M2n-]y C + may optionally be reacted in the presence of at least one solvent in a range of from 丨〇乞 to 5 ,, preferably at a temperature of from 15 ° C to 30 ° C. , wherein ... is defined as any one of items 1 to 4 of the patent application scope, and Α· represents an anion selected from the group consisting of cr, Br-, pf6. BF4· and F_, wherein M2 is as claimed It is defined in any one of the claims 1 to 4 and is not selected from the following one of the cations Na+, K+, Li+ and NR4+, whereby each R independently represents hydrazine or an alkyl group, thereby obtaining A metal complex having the general formula [Mim + ]x[M2n1y, which can be optionally purified and/or isolated. 13. A light-emitting device comprising an emissive layer, including as claimed in the patent The emissive layer of a luminescent material of the range 1 is excited at a wavelength between 300 nm and 500 nm, or across When the emissive layer applies a voltage, it can emit light having a CIE 1931 coordinate (X, y) in a range from (0.200, 0.200) to (0.550, 0.500). 14. As described in claim 13 The illuminating device further includes a light source capable of emitting light at a wavelength of -71 - 201041999 between 250 nm and 500 nm. The light-emitting device of claim 13, wherein The emissive layer is the only luminescent layer of the device. -72-
TW099103172A 2009-02-06 2010-02-03 Complex salts for light emitting devices TW201041999A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09152301A EP2223986A1 (en) 2009-02-06 2009-02-06 Complex salts for light emitting devices

Publications (1)

Publication Number Publication Date
TW201041999A true TW201041999A (en) 2010-12-01

Family

ID=40673303

Family Applications (1)

Application Number Title Priority Date Filing Date
TW099103172A TW201041999A (en) 2009-02-06 2010-02-03 Complex salts for light emitting devices

Country Status (7)

Country Link
US (1) US20120012790A1 (en)
EP (2) EP2223986A1 (en)
JP (1) JP2012516924A (en)
KR (1) KR20110120313A (en)
CN (1) CN102307966A (en)
TW (1) TW201041999A (en)
WO (1) WO2010089393A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8545996B2 (en) 2009-11-02 2013-10-01 The University Of Southern California Ion-pairing soft salts based on organometallic complexes and their applications in organic light emitting diodes
DE102010055902A1 (en) * 2010-12-23 2012-06-28 Merck Patent Gmbh Organic electroluminescent device
US9293553B2 (en) * 2011-03-10 2016-03-22 The Trustees Of Columbia University In The City Of New York Graphene electrodes for electronic devices
JP2012255959A (en) * 2011-06-10 2012-12-27 Nitto Denko Corp Coating liquid, optical anisotropic film, and image display device
DE102013202250A1 (en) * 2013-02-12 2014-08-14 Siemens Aktiengesellschaft Emitter layers with a matrix material containing asymmetrically substituted guanidinium cations
US9306179B2 (en) * 2013-11-08 2016-04-05 Universal Display Corporation Organic electroluminescent materials and devices
KR102465383B1 (en) * 2015-11-02 2022-11-10 삼성디스플레이 주식회사 Organic light emitting device and method for manufacturing the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766952A (en) * 1996-07-25 1998-06-16 Regents Of The University Of Minnesota Vapochromic platinum-complexes and salts
EP1771528A1 (en) * 2004-07-21 2007-04-11 Koninklijke Philips Electronics N.V. Light-emitting electrochemical cell
WO2006024997A1 (en) 2004-09-02 2006-03-09 Koninklijke Philips Electronics N.V. White light-emitting device
TW200611899A (en) * 2004-10-13 2006-04-16 Hirose Engineering Co Ltd Metal-containing coordination compound, high molecular compound containing coordination compound residue, organic electroluminescence material, white organic electroluminescence material, white light emitting device and light emitting device
GB0423506D0 (en) * 2004-10-22 2004-11-24 Univ Belfast Light emitting complex salts
EP2036913A3 (en) * 2005-06-30 2009-04-08 Koninklijke Philips Electronics N.V. Electro luminescent metal complexes
CN102227439B (en) * 2008-10-02 2015-08-19 巴斯夫欧洲公司 Complex salt

Also Published As

Publication number Publication date
CN102307966A (en) 2012-01-04
JP2012516924A (en) 2012-07-26
WO2010089393A2 (en) 2010-08-12
KR20110120313A (en) 2011-11-03
WO2010089393A3 (en) 2010-10-21
EP2223986A1 (en) 2010-09-01
EP2393901A2 (en) 2011-12-14
US20120012790A1 (en) 2012-01-19

Similar Documents

Publication Publication Date Title
US10586934B2 (en) Light-emitting element
Jurgensen et al. Sulfone-based deep blue thermally activated delayed fluorescence emitters: solution-processed organic light-emitting diodes with high efficiency and brightness
TWI716792B (en) Light-emitting element
TWI738276B (en) Light-emitting element
Yu et al. High-efficiency white organic light-emitting devices based on a highly amorphous iridium (III) orange phosphor
Li et al. Difluoroboron-enabled thermally activated delayed fluorescence
TWI779018B (en) High molecular weight compound having substituted triarylamine skeleton
TW201041999A (en) Complex salts for light emitting devices
JP2009536656A (en) Crosslinkable hole transport materials for organic light emitting devices
TW200822796A (en) Light emitting device containing phosphorescent complex
KR20110126648A (en) Ambipolar host in organic light emitting diode
TW201035285A (en) Luminescent element material and luminescent element
Hou et al. Highly Efficient Deep-Blue Electroluminescence from a A− π–D− π–A Structure Based Fluoresence Material with Exciton Utilizing Efficiency above 25%
TW201739746A (en) Hetero-cyclic compound and organic light emitting device comprising the same
Stanitska et al. Exciplex-Forming Systems of Physically Mixed and Covalently Bonded Benzoyl-1 H-1, 2, 3-Triazole and Carbazole Moieties for Solution-Processed White OLEDs
TW201946918A (en) N-heteroarylene compounds with low LUMO energies
Bi et al. Triphenylsilyl-Promoted Iridium Complex for High-Performance Green-Yellow Phosphorescent Organic Light-Emitting Diodes
JP7443038B2 (en) Compounds, compositions, liquid compositions and organic electroluminescent devices
Li et al. All-Solution-Processed Multilayered White Polymer Light-Emitting Diodes (WPLEDs) Based on Cross-Linked [Ir (4-vb-PBI) 2 (acac)]
TW202406972A (en) High molecular weight compounds and organic electroluminescent devices using the same
CN114502547A (en) Organic semiconductor layer, organic electronic device comprising the same, and compound thereof
TW200909441A (en) Bis-triphenylsilyl compounds and application in organic electronic component